{"transactions":[{"id":711139,"issuer":{"id":7572,"kind":"organization","name":"Cellectar Biosciences, Inc."},"owners":[{"id":30981,"kind":"person","name":"Loren Stefan","position":1,"cik":"0001441500","reported_name":"Loren Stefan","relationship":{"director":false,"officer":false,"ten_percent_owner":false,"other":true,"other_text":"Consultant"}}],"security":"Stock option (right to buy)","published_at":"2026-07-10T21:00:13.000Z","date":"2026-07-08","kind":"grant","planned":false,"acquired":true,"shares":15000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"This option shall vest in full on July 8, 2027, subject to the reporting person's continued service through the applicable vesting date."}],"balance_after":15000,"derivative":{"exercise_price":2.69,"expiration_date":"2036-07-08","underlying":"Common stock","underlying_shares":15000},"source":{"system":"sec-edgar","filing":"0001104659-26-082761","document":"tm2620238-1_4aseq1.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1441500/000110465926082761/tm2620238-1_4aseq1.xml","form_type":"4/A","original_submission_date":"2026-07-08"}},{"id":712537,"issuer":{"id":7572,"kind":"organization","name":"Cellectar Biosciences, Inc."},"owners":[{"id":31411,"kind":"person","name":"Kolean Chad J","position":1,"cik":"0001616753","reported_name":"Kolean Chad J","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CFO"}}],"security":"Stock option (right to buy)","published_at":"2026-07-09T01:13:50.000Z","date":"2026-07-07","kind":"grant","planned":false,"acquired":true,"shares":92000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"date","element":"transactionDate","label":"F1","text":"This option was contingently granted on May 28, 2026, subject to approval by Cellectar's stockholders of Cellectar's amended 2021 Stock Incentive Plan at Cellectar's 2026 Annual Meeting of Stockholders. Such stockholder approval was obtained on July 7, 2026."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"This option shall vest over a period of three years from May 28, 2026, with 1/3 vesting on the first anniversary of May 28, 2026, and the remainder vesting in 24 equal monthly installments over a 24-month period beginning on the first anniversary of May 28, 2026."}],"balance_after":92000,"derivative":{"exercise_price":3.14,"expiration_date":"2036-05-28","underlying":"Common stock","underlying_shares":92000},"source":{"system":"sec-edgar","filing":"0001104659-26-082018","document":"tm2620095-9_4seq1.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1279704/000110465926082018/tm2620095-9_4seq1.xml","form_type":"4"}},{"id":712987,"issuer":{"id":7572,"kind":"organization","name":"Cellectar Biosciences, Inc."},"owners":[{"id":31497,"kind":"person","name":"DRISCOLL FREDERICK W","position":1,"cik":"0001129890","reported_name":"DRISCOLL FREDERICK W","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock option (right to buy)","published_at":"2026-07-09T01:10:28.000Z","date":"2026-07-07","kind":"grant","planned":false,"acquired":true,"shares":25000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"This option shall vest in full on July 7, 2027, subject to the reporting person's continued service through the applicable vesting date."}],"balance_after":25000,"derivative":{"exercise_price":2.7,"expiration_date":"2036-07-07","underlying":"Common stock","underlying_shares":25000},"source":{"system":"sec-edgar","filing":"0001104659-26-082016","document":"tm2620095-8_4seq1.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1129890/000110465926082016/tm2620095-8_4seq1.xml","form_type":"4"}},{"id":712741,"issuer":{"id":7572,"kind":"organization","name":"Cellectar Biosciences, Inc."},"owners":[{"id":31455,"kind":"person","name":"Chanan-Khan Asher","position":1,"cik":"0001869837","reported_name":"Chanan-Khan Asher","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock option (right to buy)","published_at":"2026-07-09T01:09:03.000Z","date":"2026-07-07","kind":"grant","planned":false,"acquired":true,"shares":25000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"This option shall vest in full on July 7, 2027, subject to the reporting person's continued service through the applicable vesting date."}],"balance_after":25000,"derivative":{"exercise_price":2.7,"expiration_date":"2036-07-07","underlying":"Common stock","underlying_shares":25000},"source":{"system":"sec-edgar","filing":"0001104659-26-082015","document":"tm2620095-7_4seq1.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1869837/000110465926082015/tm2620095-7_4seq1.xml","form_type":"4"}},{"id":712536,"issuer":{"id":7572,"kind":"organization","name":"Cellectar Biosciences, Inc."},"owners":[{"id":31410,"kind":"person","name":"CARUSO JAMES V","position":1,"cik":"0001202770","reported_name":"CARUSO JAMES V","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President & CEO"}}],"security":"Stock option (right to buy)","published_at":"2026-07-09T01:07:56.000Z","date":"2026-07-07","kind":"grant","planned":false,"acquired":true,"shares":250000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"date","element":"transactionDate","label":"F1","text":"This option was contingently granted on May 28, 2026, subject to approval by Cellectar's stockholders of Cellectar's amended 2021 Stock Incentive Plan at Cellectar's 2026 Annual Meeting of Stockholders. Such stockholder approval was obtained on July 7, 2026."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"This option shall vest over a period of three years from May 28, 2026, with 1/3 vesting on the first anniversary of May 28, 2026, and the remainder vesting in 24 equal monthly installments over a 24-month period beginning on the first anniversary of May 28, 2026"}],"balance_after":250000,"derivative":{"exercise_price":3.14,"expiration_date":"2036-05-28","underlying":"Common stock","underlying_shares":250000},"source":{"system":"sec-edgar","filing":"0001104659-26-082014","document":"tm2620095-6_4seq1.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1279704/000110465926082014/tm2620095-6_4seq1.xml","form_type":"4"}},{"id":712535,"issuer":{"id":7572,"kind":"organization","name":"Cellectar Biosciences, Inc."},"owners":[{"id":31409,"kind":"person","name":"Gu Andrew","position":1,"cik":"0002137966","reported_name":"Gu Andrew","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock option (right to buy)","published_at":"2026-07-09T01:06:47.000Z","date":"2026-07-07","kind":"grant","planned":false,"acquired":true,"shares":25000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"This option shall vest in full on July 7, 2027, subject to the reporting person's continued service through the applicable vesting date."}],"balance_after":25000,"derivative":{"exercise_price":2.7,"expiration_date":"2036-07-07","underlying":"Common stock","underlying_shares":25000},"source":{"system":"sec-edgar","filing":"0001104659-26-082013","document":"tm2620095-5_4seq1.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1279704/000110465926082013/tm2620095-5_4seq1.xml","form_type":"4"}},{"id":712533,"issuer":{"id":7572,"kind":"organization","name":"Cellectar Biosciences, Inc."},"owners":[{"id":31407,"kind":"person","name":"Longcor Jarrod","position":1,"cik":"0001545565","reported_name":"Longcor Jarrod","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Operating Officer"}}],"security":"Stock option (right to buy)","published_at":"2026-07-09T01:05:29.000Z","date":"2026-07-07","kind":"grant","planned":false,"acquired":true,"shares":118000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"date","element":"transactionDate","label":"F1","text":"This option was contingently granted on May 28, 2026, subject to approval by Cellectar's stockholders of Cellectar's amended 2021 Stock Incentive Plan at Cellectar's 2026 Annual Meeting of Stockholders. Such stockholder approval was obtained on July 7, 2026."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"This option shall vest over a period of three years from May 28, 2026, with 1/3 vesting on the first anniversary of May 28, 2026, and the remainder vesting in 24 equal monthly installments over a 24-month period beginning on the first anniversary of May 28, 2026"}],"balance_after":118000,"derivative":{"exercise_price":3.14,"expiration_date":"2036-05-28","underlying":"Common stock","underlying_shares":118000},"source":{"system":"sec-edgar","filing":"0001104659-26-082012","document":"tm2620095-4_4seq1.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1279704/000110465926082012/tm2620095-4_4seq1.xml","form_type":"4"}},{"id":712534,"issuer":{"id":7572,"kind":"organization","name":"Cellectar Biosciences, Inc."},"owners":[{"id":31408,"kind":"person","name":"Swirsky Douglas J","position":1,"cik":"0001375884","reported_name":"Swirsky Douglas J","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock option (right to buy)","published_at":"2026-07-09T01:04:01.000Z","date":"2026-07-07","kind":"grant","planned":false,"acquired":true,"shares":37500,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"This option shall vest in full on July 7, 2027, subject to the reporting person's continued service through the applicable vesting date."}],"balance_after":37500,"derivative":{"exercise_price":2.7,"expiration_date":"2036-07-07","underlying":"Common stock","underlying_shares":37500},"source":{"system":"sec-edgar","filing":"0001104659-26-082011","document":"tm2620095-3_4seq1.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1279704/000110465926082011/tm2620095-3_4seq1.xml","form_type":"4"}},{"id":712972,"issuer":{"id":7572,"kind":"organization","name":"Cellectar Biosciences, Inc."},"owners":[{"id":31493,"kind":"person","name":"NEIS JOHN","position":1,"cik":"0001167426","reported_name":"NEIS JOHN","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock option (right to buy)","published_at":"2026-07-09T01:02:54.000Z","date":"2026-07-07","kind":"grant","planned":false,"acquired":true,"shares":25000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"This option shall vest in full on July 7, 2027, subject to the reporting person's continued service through the applicable vesting date."}],"balance_after":25000,"derivative":{"exercise_price":2.7,"expiration_date":"2036-07-07","underlying":"Common stock","underlying_shares":25000},"source":{"system":"sec-edgar","filing":"0001104659-26-082010","document":"tm2620095-2_4seq1.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1167426/000110465926082010/tm2620095-2_4seq1.xml","form_type":"4"}},{"id":712562,"issuer":{"id":7572,"kind":"organization","name":"Cellectar Biosciences, Inc."},"owners":[{"id":30981,"kind":"person","name":"Loren Stefan","position":1,"cik":"0001441500","reported_name":"Loren Stefan","relationship":{"director":false,"officer":false,"ten_percent_owner":false,"other":true,"other_text":"Consultant"}}],"security":"Stock option (right to buy)","published_at":"2026-07-09T01:00:38.000Z","date":"2026-07-08","kind":"grant","planned":false,"acquired":true,"shares":15000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"This option shall vest in full on July 8, 2027, subject to the reporting person's continued service through the applicable vesting date."}],"balance_after":15000,"derivative":{"exercise_price":2.68,"expiration_date":"2036-07-08","underlying":"Common stock","underlying_shares":15000},"source":{"system":"sec-edgar","filing":"0001104659-26-082009","document":"tm2620095-1_4seq1.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1441500/000110465926082009/tm2620095-1_4seq1.xml","form_type":"4"}},{"id":784556,"issuer":{"id":7572,"kind":"organization","name":"Cellectar Biosciences, Inc."},"owners":[{"id":31407,"kind":"person","name":"Longcor Jarrod","position":1,"cik":"0001545565","reported_name":"Longcor Jarrod","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Operating Officer"}}],"security":"Warrants","published_at":"2026-05-12T00:07:18.000Z","date":"2026-05-07","kind":"purchase","planned":false,"acquired":true,"shares":26040,"price":0.01,"value":260.4,"ownership":{"direct":true},"footnotes":[{"field":"derivative.expiration_date","element":"expirationDate","label":"F1","text":"Expiration dates are as follows: Tranche A shall have a one-year term from the date of stockholder approval; Tranche B shall have a two-year term from the date of stockholder approval; Tranche C shall have a five-year term from the date of stockholder approval."}],"balance_after":36149,"derivative":{"exercise_price":2.88,"exercise_date":"2026-05-07","underlying":"Common Stock","underlying_shares":26040},"source":{"system":"sec-edgar","filing":"0001104659-26-058854","document":"tm2614289-2_4seq1.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1279704/000110465926058854/tm2614289-2_4seq1.xml","form_type":"4"}},{"id":784555,"issuer":{"id":7572,"kind":"organization","name":"Cellectar Biosciences, Inc."},"owners":[{"id":31407,"kind":"person","name":"Longcor Jarrod","position":1,"cik":"0001545565","reported_name":"Longcor Jarrod","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Operating Officer"}}],"security":"Common Stock","published_at":"2026-05-12T00:07:18.000Z","date":"2026-05-07","kind":"purchase","planned":false,"acquired":true,"shares":8680,"price":2.88,"value":24998.4,"ownership":{"direct":true},"balance_after":20451,"source":{"system":"sec-edgar","filing":"0001104659-26-058854","document":"tm2614289-2_4seq1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1279704/000110465926058854/tm2614289-2_4seq1.xml","form_type":"4"}},{"id":784554,"issuer":{"id":7572,"kind":"organization","name":"Cellectar Biosciences, Inc."},"owners":[{"id":31410,"kind":"person","name":"CARUSO JAMES V","position":1,"cik":"0001202770","reported_name":"CARUSO JAMES V","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Warrants","published_at":"2026-05-12T00:05:44.000Z","date":"2026-05-07","kind":"purchase","planned":false,"acquired":true,"shares":26040,"price":0.01,"value":260.4,"ownership":{"direct":true},"footnotes":[{"field":"derivative.expiration_date","element":"expirationDate","label":"F1","text":"Expiration dates are as follows: Tranche A shall have a one-year term from the date of stockholder approval; Tranche B shall have a two-year term from the date of stockholder approval; Tranche C shall have a five-year term from the date of stockholder approval."}],"balance_after":36076,"derivative":{"exercise_price":2.88,"exercise_date":"2026-05-07","underlying":"Common Stock","underlying_shares":26040},"source":{"system":"sec-edgar","filing":"0001104659-26-058851","document":"tm2614289-1_4seq1.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1279704/000110465926058851/tm2614289-1_4seq1.xml","form_type":"4"}},{"id":784553,"issuer":{"id":7572,"kind":"organization","name":"Cellectar Biosciences, Inc."},"owners":[{"id":31410,"kind":"person","name":"CARUSO JAMES V","position":1,"cik":"0001202770","reported_name":"CARUSO JAMES V","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Common Stock","published_at":"2026-05-12T00:05:44.000Z","date":"2026-05-07","kind":"purchase","planned":false,"acquired":true,"shares":8680,"price":2.88,"value":24998.4,"ownership":{"direct":true},"balance_after":20318,"source":{"system":"sec-edgar","filing":"0001104659-26-058851","document":"tm2614289-1_4seq1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1279704/000110465926058851/tm2614289-1_4seq1.xml","form_type":"4"}},{"id":967992,"issuer":{"id":7572,"kind":"organization","name":"Cellectar Biosciences, Inc."},"owners":[{"id":31493,"kind":"person","name":"NEIS JOHN","position":1,"cik":"0001167426","reported_name":"NEIS JOHN","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2025-12-16T23:00:11.000Z","date":"2025-12-12","kind":"sale","planned":false,"acquired":false,"shares":198,"price":3.6969,"value":731.9862,"ownership":{"direct":false,"nature":"See Footnote"},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The price reported is a weighted average price. These shares were sold in multiple transactions at prices ranging from $3.631 to $3.70, inclusive. The reporting person has provided to the Issuer, and undertakes to provide to any security holder of the Issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in Footnote (1) to this Form 4."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"This number has been adjusted for (i) the one-for-thirty (1:30) reverse stock split effected by the Issuer on June 24, 2025, (ii) the one-for-ten (1:10) reverse stock split effected by the Issuer on July 21, 2022, and (iii) the one-for-ten (1:10) reverse stock split effected by the Issuer on July 16, 2018."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F3","text":"These securities are held by Advantage Capital Wisconsin Partners I, Limited Partnership. Venture Investors LLC is the submanager and special limited partner of Advantage Capital Wisconsin Partners I, Limited Partnership. The investment decisions of Venture Investors LLC are made collectively by five managers, including the reporting person. The reporting person disclaims beneficial ownership of such securities except to the extent of his pecuniary interest herein."}],"balance_after":10,"source":{"system":"sec-edgar","filing":"0001104659-25-121691","document":"tm2533642-1_4seq1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1167426/000110465925121691/tm2533642-1_4seq1.xml","form_type":"4"}},{"id":1092112,"issuer":{"id":7572,"kind":"organization","name":"Cellectar Biosciences, Inc."},"owners":[{"id":31410,"kind":"person","name":"CARUSO JAMES V","position":1,"cik":"0001202770","reported_name":"CARUSO JAMES V","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Warrants","published_at":"2025-07-03T12:02:08.000Z","date":"2025-07-02","kind":"purchase","planned":false,"acquired":true,"shares":10000,"price":0.01,"value":100.0,"ownership":{"direct":true},"balance_after":10000,"derivative":{"exercise_price":5.25,"exercise_date":"2025-07-02","expiration_date":"2030-07-02","underlying":"Common Stock","underlying_shares":10000},"source":{"system":"sec-edgar","filing":"0001104659-25-065573","document":"tm2519819-3_4seq1.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1279704/000110465925065573/tm2519819-3_4seq1.xml","form_type":"4"}},{"id":1092111,"issuer":{"id":7572,"kind":"organization","name":"Cellectar Biosciences, Inc."},"owners":[{"id":31410,"kind":"person","name":"CARUSO JAMES V","position":1,"cik":"0001202770","reported_name":"CARUSO JAMES V","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Common Stock","published_at":"2025-07-03T12:02:08.000Z","date":"2025-07-02","kind":"purchase","planned":false,"acquired":true,"shares":10000,"price":4.99,"value":49900.0,"ownership":{"direct":true},"footnotes":[{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F1","text":"This number has been adjusted for the one-for-thirty (1:30) reverse stock split effected by the Issuer on June 24, 2025."}],"balance_after":11638,"source":{"system":"sec-edgar","filing":"0001104659-25-065573","document":"tm2519819-3_4seq1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1279704/000110465925065573/tm2519819-3_4seq1.xml","form_type":"4"}},{"id":1092110,"issuer":{"id":7572,"kind":"organization","name":"Cellectar Biosciences, Inc."},"owners":[{"id":31407,"kind":"person","name":"Longcor Jarrod","position":1,"cik":"0001545565","reported_name":"Longcor Jarrod","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Operating Officer"}}],"security":"Warrants","published_at":"2025-07-03T12:01:18.000Z","date":"2025-07-02","kind":"purchase","planned":false,"acquired":true,"shares":10000,"price":0.01,"value":100.0,"ownership":{"direct":true},"balance_after":10000,"derivative":{"exercise_price":5.25,"exercise_date":"2025-07-02","expiration_date":"2030-07-02","underlying":"Common Stock","underlying_shares":10000},"source":{"system":"sec-edgar","filing":"0001104659-25-065572","document":"tm2519819-2_4seq1.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1279704/000110465925065572/tm2519819-2_4seq1.xml","form_type":"4"}},{"id":1092109,"issuer":{"id":7572,"kind":"organization","name":"Cellectar Biosciences, Inc."},"owners":[{"id":31407,"kind":"person","name":"Longcor Jarrod","position":1,"cik":"0001545565","reported_name":"Longcor Jarrod","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Operating Officer"}}],"security":"Common Stock","published_at":"2025-07-03T12:01:18.000Z","date":"2025-07-02","kind":"purchase","planned":false,"acquired":true,"shares":10000,"price":4.99,"value":49900.0,"ownership":{"direct":true},"footnotes":[{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F1","text":"This number has been adjusted for the one-for-thirty (1:30) reverse stock split effected by the Issuer on June 24, 2025."}],"balance_after":12768,"source":{"system":"sec-edgar","filing":"0001104659-25-065572","document":"tm2519819-2_4seq1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1279704/000110465925065572/tm2519819-2_4seq1.xml","form_type":"4"}},{"id":1092107,"issuer":{"id":7572,"kind":"organization","name":"Cellectar Biosciences, Inc."},"owners":[{"id":31411,"kind":"person","name":"Kolean Chad J","position":1,"cik":"0001616753","reported_name":"Kolean Chad J","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Warrants","published_at":"2025-07-03T12:00:13.000Z","date":"2025-07-02","kind":"purchase","planned":false,"acquired":true,"shares":5000,"price":0.01,"value":50.0,"ownership":{"direct":true},"balance_after":5000,"derivative":{"exercise_price":5.25,"exercise_date":"2025-07-02","expiration_date":"2030-07-02","underlying":"Common Stock","underlying_shares":5000},"source":{"system":"sec-edgar","filing":"0001104659-25-065570","document":"tm2519819-1_4seq1.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1279704/000110465925065570/tm2519819-1_4seq1.xml","form_type":"4"}},{"id":1092106,"issuer":{"id":7572,"kind":"organization","name":"Cellectar Biosciences, Inc."},"owners":[{"id":31411,"kind":"person","name":"Kolean Chad J","position":1,"cik":"0001616753","reported_name":"Kolean Chad J","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Common Stock","published_at":"2025-07-03T12:00:13.000Z","date":"2025-07-02","kind":"purchase","planned":false,"acquired":true,"shares":5000,"price":4.99,"value":24950.0,"ownership":{"direct":true},"footnotes":[{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F1","text":"This number has been adjusted for the one-for-thirty (1:30) reverse stock split effected by the Issuer on June 24, 2025."}],"balance_after":6418,"source":{"system":"sec-edgar","filing":"0001104659-25-065570","document":"tm2519819-1_4seq1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1279704/000110465925065570/tm2519819-1_4seq1.xml","form_type":"4"}},{"id":1209428,"issuer":{"id":7572,"kind":"organization","name":"Cellectar Biosciences, Inc."},"owners":[{"id":31407,"kind":"person","name":"Longcor Jarrod","position":1,"cik":"0001545565","reported_name":"Longcor Jarrod","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Operating Officer"}}],"security":"Common Stock","published_at":"2025-03-13T01:44:18.000Z","date":"2025-01-10","kind":"purchase","planned":false,"acquired":true,"shares":30000,"price":0.28,"value":8400.0,"ownership":{"direct":true},"balance_after":83141,"source":{"system":"sec-edgar","filing":"0001104659-25-023121","document":"tm259066-1_4seq1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1279704/000110465925023121/tm259066-1_4seq1.xml","form_type":"4"}},{"id":1263513,"issuer":{"id":7572,"kind":"organization","name":"Cellectar Biosciences, Inc."},"owners":[{"id":31408,"kind":"person","name":"Swirsky Douglas J","position":1,"cik":"0001375884","reported_name":"Swirsky Douglas J","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock option (right to buy)","published_at":"2025-02-18T21:07:24.000Z","date":"2025-02-14","kind":"grant","planned":false,"acquired":true,"shares":90000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"This option shall vest in full on February 14, 2026, subject to the reporting person's continued service through the applicable vesting date."}],"balance_after":90000,"derivative":{"exercise_price":0.29,"expiration_date":"2035-02-14","underlying":"Common Stock","underlying_shares":90000},"source":{"system":"sec-edgar","filing":"0001104659-25-014757","document":"tm256830-8_4seq1.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1279704/000110465925014757/tm256830-8_4seq1.xml","form_type":"4"}},{"id":1264492,"issuer":{"id":7572,"kind":"organization","name":"Cellectar Biosciences, Inc."},"owners":[{"id":31493,"kind":"person","name":"NEIS JOHN","position":1,"cik":"0001167426","reported_name":"NEIS JOHN","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock option (right to buy)","published_at":"2025-02-18T21:06:31.000Z","date":"2025-02-14","kind":"grant","planned":false,"acquired":true,"shares":60000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"This option shall vest in full on February 14, 2026, subject to the reporting person's continued service through the applicable vesting date."}],"balance_after":60000,"derivative":{"exercise_price":0.29,"expiration_date":"2035-02-14","underlying":"Common Stock","underlying_shares":60000},"source":{"system":"sec-edgar","filing":"0001104659-25-014753","document":"tm256830d7_4seq1.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1167426/000110465925014753/tm256830d7_4seq1.xml","form_type":"4"}},{"id":1263621,"issuer":{"id":7572,"kind":"organization","name":"Cellectar Biosciences, Inc."},"owners":[{"id":30981,"kind":"person","name":"Loren Stefan","position":1,"cik":"0001441500","reported_name":"Loren Stefan","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock option (right to buy)","published_at":"2025-02-18T21:05:52.000Z","date":"2025-02-14","kind":"grant","planned":false,"acquired":true,"shares":60000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"This option shall vest in full on February 14, 2026, subject to the reporting person's continued service through the applicable vesting date."}],"balance_after":60000,"derivative":{"exercise_price":0.29,"expiration_date":"2035-02-14","underlying":"Common Stock","underlying_shares":60000},"source":{"system":"sec-edgar","filing":"0001104659-25-014752","document":"tm256830-6_4seq1.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1441500/000110465925014752/tm256830-6_4seq1.xml","form_type":"4"}},{"id":1263511,"issuer":{"id":7572,"kind":"organization","name":"Cellectar Biosciences, Inc."},"owners":[{"id":31407,"kind":"person","name":"Longcor Jarrod","position":1,"cik":"0001545565","reported_name":"Longcor Jarrod","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Operating Officer"}}],"security":"Stock option (right to buy)","published_at":"2025-02-18T21:05:07.000Z","date":"2025-02-14","kind":"grant","planned":false,"acquired":true,"shares":500000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"This option shall vest over a period of three years from February 14, 2025, with 1/3 vesting on the first anniversary of February 14, 2026 and the remainder\nvesting in 24 equal monthly installments over a 24-month period beginning on the first anniversary of February 14, 2026."}],"balance_after":500000,"derivative":{"exercise_price":0.29,"expiration_date":"2035-02-14","underlying":"Common Stock","underlying_shares":500000},"source":{"system":"sec-edgar","filing":"0001104659-25-014744","document":"tm256830-5_4seq1.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1279704/000110465925014744/tm256830-5_4seq1.xml","form_type":"4"}},{"id":1263512,"issuer":{"id":7572,"kind":"organization","name":"Cellectar Biosciences, Inc."},"owners":[{"id":31411,"kind":"person","name":"Kolean Chad J","position":1,"cik":"0001616753","reported_name":"Kolean Chad J","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Stock option (right to buy)","published_at":"2025-02-18T21:04:18.000Z","date":"2025-02-14","kind":"grant","planned":false,"acquired":true,"shares":290000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"This option shall vest over a period of three years from February 14, 2025, with 1/3 vesting on the first anniversary of February 14, 2026 and the remainder vesting in 24 equal monthly installments over a 24-month period beginning on the first anniversary of February 14, 2026."}],"balance_after":290000,"derivative":{"exercise_price":0.29,"expiration_date":"2035-02-14","underlying":"Common Stock","underlying_shares":290000},"source":{"system":"sec-edgar","filing":"0001104659-25-014742","document":"tm256830-4_4seq1.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1279704/000110465925014742/tm256830-4_4seq1.xml","form_type":"4"}},{"id":1264564,"issuer":{"id":7572,"kind":"organization","name":"Cellectar Biosciences, Inc."},"owners":[{"id":31497,"kind":"person","name":"DRISCOLL FREDERICK W","position":1,"cik":"0001129890","reported_name":"DRISCOLL FREDERICK W","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock option (right to buy)","published_at":"2025-02-18T21:03:34.000Z","date":"2025-02-14","kind":"grant","planned":false,"acquired":true,"shares":60000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"This option shall vest in full on February 14, 2026, subject to the reporting person's continued service through the applicable vesting date."}],"balance_after":60000,"derivative":{"exercise_price":0.29,"expiration_date":"2035-02-14","underlying":"Common Stock","underlying_shares":60000},"source":{"system":"sec-edgar","filing":"0001104659-25-014740","document":"tm256830-3_4seq1.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1129890/000110465925014740/tm256830-3_4seq1.xml","form_type":"4"}},{"id":1264039,"issuer":{"id":7572,"kind":"organization","name":"Cellectar Biosciences, Inc."},"owners":[{"id":31455,"kind":"person","name":"Chanan-Khan Asher","position":1,"cik":"0001869837","reported_name":"Chanan-Khan Asher","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock option (right to buy)","published_at":"2025-02-18T21:02:37.000Z","date":"2025-02-14","kind":"grant","planned":false,"acquired":true,"shares":60000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"This option shall vest in full on February 14, 2026, subject to the reporting person's continued service through the applicable vesting date."}],"balance_after":60000,"derivative":{"exercise_price":0.29,"expiration_date":"2035-02-14","underlying":"Common Stock","underlying_shares":60000},"source":{"system":"sec-edgar","filing":"0001104659-25-014737","document":"tm256830-2_4seq1.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1869837/000110465925014737/tm256830-2_4seq1.xml","form_type":"4"}},{"id":1263508,"issuer":{"id":7572,"kind":"organization","name":"Cellectar Biosciences, Inc."},"owners":[{"id":31410,"kind":"person","name":"CARUSO JAMES V","position":1,"cik":"0001202770","reported_name":"CARUSO JAMES V","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and CEO"}}],"security":"Stock option (right to buy)","published_at":"2025-02-18T21:01:16.000Z","date":"2025-02-14","kind":"grant","planned":false,"acquired":true,"shares":900000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"This option shall vest over a period of three years from February 14, 2025, with 1/3 vesting on the first anniversary of February 14, 2026 and the remainder vesting in 24 equal monthly installments over a 24-month period beginning on the first anniversary of February 14, 2026."}],"balance_after":900000,"derivative":{"exercise_price":0.29,"expiration_date":"2035-02-14","underlying":"Common Stock","underlying_shares":900000},"source":{"system":"sec-edgar","filing":"0001104659-25-014730","document":"tm256830-1_4seq1.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1279704/000110465925014730/tm256830-1_4seq1.xml","form_type":"4"}},{"id":1475025,"issuer":{"id":7572,"kind":"organization","name":"Cellectar Biosciences, Inc."},"owners":[{"id":31407,"kind":"person","name":"Longcor Jarrod","position":1,"cik":"0001545565","reported_name":"Longcor Jarrod","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Operating Officer"}}],"security":"Stock option (right to buy)","published_at":"2024-06-18T21:04:49.000Z","date":"2024-06-14","kind":"grant","planned":false,"acquired":true,"shares":500000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"date","element":"transactionDate","label":"F1","text":"This option was contingently granted on December 15, 2023, subject to approval by Cellectar's stockholders of Cellectar's amended 2021 Stock Incentive Plan at Cellectar's 2024 Annual Meeting of Stockholders.  Such stockholder approval was obtained on June 14, 2024."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"This option shall vest over a period of three years from December 15, 2023, with 1/3 vesting on the first anniversary of Decembner 15, 2023 and the remainder vesting in 24 equal monthly installments over a 24-month period beginning on the first anniversary of Decembner 15, 2023."}],"balance_after":500000,"derivative":{"exercise_price":2.65,"expiration_date":"2033-12-15","underlying":"Common Stock","underlying_shares":500000},"source":{"system":"sec-edgar","filing":"0001104659-24-072891","document":"tm2417520-10_4seq1.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1279704/000110465924072891/tm2417520-10_4seq1.xml","form_type":"4"}},{"id":1475023,"issuer":{"id":7572,"kind":"organization","name":"Cellectar Biosciences, Inc."},"owners":[{"id":31410,"kind":"person","name":"CARUSO JAMES V","position":1,"cik":"0001202770","reported_name":"CARUSO JAMES V","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and CEO"}}],"security":"Stock option (right to buy)","published_at":"2024-06-18T21:04:27.000Z","date":"2024-06-14","kind":"grant","planned":false,"acquired":true,"shares":900000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"date","element":"transactionDate","label":"F1","text":"This option was contingently granted on December 15, 2023, subject to approval by Cellectar's stockholders of Cellectar's amended 2021 Stock Incentive Plan at Cellectar's 2024 Annual Meeting of Stockholders. Such stockholder approval was obtained on June 14, 2024."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"This option shall vest over a period of three years from December 15, 2023, with 1/3 vesting on the first anniversary of Decembner 15, 2023 and the remainder vesting in 24 equal monthly installments over a 24-month period beginning on the first anniversary of Decembner 15, 2023."}],"balance_after":900000,"derivative":{"exercise_price":2.65,"expiration_date":"2033-12-15","underlying":"Common Stock","underlying_shares":900000},"source":{"system":"sec-edgar","filing":"0001104659-24-072889","document":"tm2417520-9_4seq1.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1279704/000110465924072889/tm2417520-9_4seq1.xml","form_type":"4"}},{"id":1475022,"issuer":{"id":7572,"kind":"organization","name":"Cellectar Biosciences, Inc."},"owners":[{"id":31411,"kind":"person","name":"Kolean Chad J","position":1,"cik":"0001616753","reported_name":"Kolean Chad J","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Stock option (right to buy)","published_at":"2024-06-18T21:04:06.000Z","date":"2024-06-14","kind":"grant","planned":false,"acquired":true,"shares":290000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"date","element":"transactionDate","label":"F1","text":"This option was contingently granted on December 15, 2023, subject to approval by Cellectar's stockholders of Cellectar's amended 2021 Stock Incentive Plan at Cellectar's 2024 Annual Meeting of Stockholders. Such stockholder approval was obtained on June 14, 2024."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"This option shall vest over a period of three years from December 15, 2023, with 1/3 vesting on the first anniversary of Decembner 15, 2023 and the remainder vesting in 24 equal monthly installments over a 24-month period beginning on the first anniversary of Decembner 15, 2023."}],"balance_after":290000,"derivative":{"exercise_price":2.65,"expiration_date":"2033-12-15","underlying":"Common Stock","underlying_shares":290000},"source":{"system":"sec-edgar","filing":"0001104659-24-072887","document":"tm2417520-8_4seq1.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1279704/000110465924072887/tm2417520-8_4seq1.xml","form_type":"4"}},{"id":1475024,"issuer":{"id":7572,"kind":"organization","name":"Cellectar Biosciences, Inc."},"owners":[{"id":89770,"kind":"person","name":"Shustov Andrei","position":1,"cik":"0001969686","reported_name":"Shustov Andrei","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Senior Vice President, Medical"}}],"security":"Stock option (right to buy)","published_at":"2024-06-18T21:03:28.000Z","date":"2024-06-14","kind":"grant","planned":false,"acquired":true,"shares":260000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"date","element":"transactionDate","label":"F1","text":"This option was contingently granted on December 15, 2023, subject to approval by Cellectar's stockholders of Cellectar's amended 2021 Stock Incentive Plan at Cellectar's 2024 Annual Meeting of Stockholders.  Such stockholder approval was obtained on June 14, 2024."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"This option shall vest over a period of three years from December 15, 2023, with 1/3 vesting on the first anniversary of Decembner 15, 2023 and the remainder vesting in 24 equal monthly installments over a 24-month period beginning on the first anniversary of Decembner 15, 2023."}],"balance_after":260000,"derivative":{"exercise_price":2.65,"expiration_date":"2033-12-15","underlying":"Common Stock","underlying_shares":260000},"source":{"system":"sec-edgar","filing":"0001104659-24-072886","document":"tm2417520-7_4seq1.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1279704/000110465924072886/tm2417520-7_4seq1.xml","form_type":"4"}},{"id":1475021,"issuer":{"id":7572,"kind":"organization","name":"Cellectar Biosciences, Inc."},"owners":[{"id":89769,"kind":"person","name":"Lea Darrell Shane","position":1,"cik":"0001958526","reported_name":"Lea Darrell Shane","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Commercial Officer"}}],"security":"Stock option (right to buy)","published_at":"2024-06-18T21:02:59.000Z","date":"2024-06-14","kind":"grant","planned":false,"acquired":true,"shares":260000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"date","element":"transactionDate","label":"F1","text":"This option was contingently granted on December 15, 2023, subject to approval by Cellectar's stockholders of Cellectar's amended 2021 Stock Incentive Plan at Cellectar's 2024 Annual Meeting of Stockholders. Such stockholder approval was obtained on June 14, 2024."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"This option shall vest over a period of three years from December 15, 2023, with 1/3 vesting on the first anniversary of Decembner 15, 2023 and the remainder vesting in 24 equal monthly installments over a 24-month period beginning on the first anniversary of Decembner 15, 2023."}],"balance_after":260000,"derivative":{"exercise_price":2.65,"expiration_date":"2033-12-15","underlying":"Common Stock","underlying_shares":260000},"source":{"system":"sec-edgar","filing":"0001104659-24-072885","document":"tm2417520-6_4seq1.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1279704/000110465924072885/tm2417520-6_4seq1.xml","form_type":"4"}},{"id":1475092,"issuer":{"id":7572,"kind":"organization","name":"Cellectar Biosciences, Inc."},"owners":[{"id":30981,"kind":"person","name":"Loren Stefan","position":1,"cik":"0001441500","reported_name":"Loren Stefan","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock option (right to buy)","published_at":"2024-06-18T21:01:59.000Z","date":"2024-06-14","kind":"grant","planned":false,"acquired":true,"shares":60000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"date","element":"transactionDate","label":"F1","text":"This option was contingently granted on December 22, 2023, subject to approval by Cellectar's stockholders of Cellectar's amended 2021 Stock Incentive Plan at Cellectar's 2024 Annual Meeting of Stockholders. Such stockholder approval was obtained on June 14, 2024."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"This option shall vest in full on December 22, 2024, subject to the reporting person's continued service through the applicable vesting date."}],"balance_after":60000,"derivative":{"exercise_price":2.58,"expiration_date":"2033-12-22","underlying":"Common Stock","underlying_shares":60000},"source":{"system":"sec-edgar","filing":"0001104659-24-072883","document":"tm2417520-5_4seq1.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1441500/000110465924072883/tm2417520-5_4seq1.xml","form_type":"4"}},{"id":1475020,"issuer":{"id":7572,"kind":"organization","name":"Cellectar Biosciences, Inc."},"owners":[{"id":31408,"kind":"person","name":"Swirsky Douglas J","position":1,"cik":"0001375884","reported_name":"Swirsky Douglas J","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock option (right to buy)","published_at":"2024-06-18T21:01:29.000Z","date":"2024-06-14","kind":"grant","planned":false,"acquired":true,"shares":90000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"date","element":"transactionDate","label":"F1","text":"This option was contingently granted on December 22, 2023, subject to approval by Cellectar's stockholders of Cellectar's amended 2021 Stock Incentive Plan at Cellectar's 2024 Annual Meeting of Stockholders.  Such stockholder approval was obtained on June 14, 2024."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"This option shall vest in full on December 22, 2024, subject to the reporting person's continued service through the applicable vesting date."}],"balance_after":90000,"derivative":{"exercise_price":2.58,"expiration_date":"2033-12-22","underlying":"Common Stock","underlying_shares":90000},"source":{"system":"sec-edgar","filing":"0001104659-24-072882","document":"tm2417520-4_4seq1.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1279704/000110465924072882/tm2417520-4_4seq1.xml","form_type":"4"}},{"id":1475864,"issuer":{"id":7572,"kind":"organization","name":"Cellectar Biosciences, Inc."},"owners":[{"id":31493,"kind":"person","name":"NEIS JOHN","position":1,"cik":"0001167426","reported_name":"NEIS JOHN","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock option (right to buy)","published_at":"2024-06-18T21:00:59.000Z","date":"2024-06-14","kind":"grant","planned":false,"acquired":true,"shares":60000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"date","element":"transactionDate","label":"F1","text":"This option was contingently granted on December 22, 2023, subject to approval by Cellectar's stockholders of Cellectar's amended 2021 Stock Incentive Plan at Cellectar's 2024 Annual Meeting of Stockholders. Such stockholder approval was obtained on June 14, 2024."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"This option shall vest in full on December 22, 2024, subject to the reporting person's continued service through the applicable vesting date."}],"balance_after":60000,"derivative":{"exercise_price":2.58,"expiration_date":"2033-12-22","underlying":"Common Stock","underlying_shares":60000},"source":{"system":"sec-edgar","filing":"0001104659-24-072881","document":"tm2417520-3_4seq1.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1167426/000110465924072881/tm2417520-3_4seq1.xml","form_type":"4"}},{"id":1475924,"issuer":{"id":7572,"kind":"organization","name":"Cellectar Biosciences, Inc."},"owners":[{"id":31497,"kind":"person","name":"DRISCOLL FREDERICK W","position":1,"cik":"0001129890","reported_name":"DRISCOLL FREDERICK W","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock option (right to buy)","published_at":"2024-06-18T21:00:33.000Z","date":"2024-06-14","kind":"grant","planned":false,"acquired":true,"shares":60000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"date","element":"transactionDate","label":"F1","text":"This option was contingently granted on December 22, 2023, subject to approval by Cellectar's stockholders of Cellectar's amended 2021 Stock Incentive Plan at Cellectar's 2024 Annual Meeting of Stockholders. Such stockholder approval was obtained on June 14, 2024."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"This option shall vest in full on December 22, 2024, subject to the reporting person's continued service through the applicable vesting date."}],"balance_after":60000,"derivative":{"exercise_price":2.58,"expiration_date":"2033-12-22","underlying":"Common Stock","underlying_shares":60000},"source":{"system":"sec-edgar","filing":"0001104659-24-072880","document":"tm2417520-2_4seq1.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1129890/000110465924072880/tm2417520-2_4seq1.xml","form_type":"4"}},{"id":1475662,"issuer":{"id":7572,"kind":"organization","name":"Cellectar Biosciences, Inc."},"owners":[{"id":31455,"kind":"person","name":"Chanan-Khan Asher","position":1,"cik":"0001869837","reported_name":"Chanan-Khan Asher","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock option (right to buy)","published_at":"2024-06-18T21:00:17.000Z","date":"2024-06-14","kind":"grant","planned":false,"acquired":true,"shares":60000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"date","element":"transactionDate","label":"F1","text":"This option was contingently granted on December 22, 2023, subject to approval by Cellectar's stockholders of Cellectar's amended 2021 Stock Incentive Plan at Cellectar's 2024 Annual Meeting of Stockholders.  Such stockholder approval was obtained on June 14, 2024."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"This option shall vest in full on December 22, 2024, subject to the reporting person's continued service through the applicable vesting date."}],"balance_after":60000,"derivative":{"exercise_price":2.58,"expiration_date":"2033-12-22","underlying":"Common Stock","underlying_shares":60000},"source":{"system":"sec-edgar","filing":"0001104659-24-072875","document":"tm2417520-1_4seq1.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1869837/000110465924072875/tm2417520-1_4seq1.xml","form_type":"4"}},{"id":1713994,"issuer":{"id":7572,"kind":"organization","name":"Cellectar Biosciences, Inc."},"owners":[{"id":89769,"kind":"person","name":"Lea Darrell Shane","position":1,"cik":"0001958526","reported_name":"Lea Darrell Shane","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Commercial Officer"}}],"security":"Stock option (right to buy)","published_at":"2023-12-13T01:09:39.000Z","date":"2023-06-23","kind":"grant","planned":false,"acquired":true,"shares":100000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"date","element":"transactionDate","label":"F1","text":"This option was contingently granted on January 16, 2023, subject to approval by Cellectar's stockholders of Cellectar's amended 2021 Stock Incentive Plan  at Cellectar's 2023 Annual Meeting of Stockholders. Such stockholder approval was obtained on June 23, 2023. Because January 16, 2023 was a federal holiday, the option was priced on the following trading day."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"This option shall vest over a period of three years from January 17, 2023, with 1/3 vesting on the first anniversary of January 17, 2023 and the remainder vesting in 24 equal monthly installments over a 24-month period beginning on the first anniversary of January 17, 2023."}],"balance_after":100000,"derivative":{"exercise_price":1.68,"expiration_date":"2033-01-17","underlying":"Common Stock","underlying_shares":100000},"source":{"system":"sec-edgar","filing":"0001104659-23-125488","document":"tm2332764-3_4seq1.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1279704/000110465923125488/tm2332764-3_4seq1.xml","form_type":"4"}},{"id":1713993,"issuer":{"id":7572,"kind":"organization","name":"Cellectar Biosciences, Inc."},"owners":[{"id":89769,"kind":"person","name":"Lea Darrell Shane","position":1,"cik":"0001958526","reported_name":"Lea Darrell Shane","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Commercial Officer"}}],"security":"Common Stock","published_at":"2023-12-13T01:09:39.000Z","date":"2023-12-08","kind":"grant","planned":false,"acquired":true,"shares":39599,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":39599,"source":{"system":"sec-edgar","filing":"0001104659-23-125488","document":"tm2332764-3_4seq1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1279704/000110465923125488/tm2332764-3_4seq1.xml","form_type":"4"}},{"id":1713990,"issuer":{"id":7572,"kind":"organization","name":"Cellectar Biosciences, Inc."},"owners":[{"id":31411,"kind":"person","name":"Kolean Chad J","position":1,"cik":"0001616753","reported_name":"Kolean Chad J","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Stock option (right to buy)","published_at":"2023-12-13T01:07:49.000Z","date":"2023-06-23","kind":"grant","planned":false,"acquired":true,"shares":104000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"date","element":"transactionDate","label":"F1","text":"This option was contingently granted on January 16, 2023, subject to approval by Cellectar's stockholders of Cellectar's amended 2021 Stock Incentive Plan at Cellectar's 2023 Annual Meeting of Stockholders. Such stockholder approval was obtained on June 23, 2023. Because January 16, 2023 was a federal holiday, the option was priced on the following trading day."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"This option shall vest over a period of three years from January 17, 2023, with 1/3 vesting on the first anniversary of January 17, 2023 and the remainder vesting in 24 equal monthly installments over a 24-month period beginning on the first anniversary of January 17, 2023."}],"balance_after":104000,"derivative":{"exercise_price":1.68,"expiration_date":"2033-01-17","underlying":"Common Stock","underlying_shares":104000},"source":{"system":"sec-edgar","filing":"0001104659-23-125486","document":"tm2332764-2_4seq1.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1279704/000110465923125486/tm2332764-2_4seq1.xml","form_type":"4"}},{"id":1713989,"issuer":{"id":7572,"kind":"organization","name":"Cellectar Biosciences, Inc."},"owners":[{"id":31411,"kind":"person","name":"Kolean Chad J","position":1,"cik":"0001616753","reported_name":"Kolean Chad J","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Common Stock","published_at":"2023-12-13T01:07:49.000Z","date":"2023-12-08","kind":"grant","planned":false,"acquired":true,"shares":42554,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":42578,"source":{"system":"sec-edgar","filing":"0001104659-23-125486","document":"tm2332764-2_4seq1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1279704/000110465923125486/tm2332764-2_4seq1.xml","form_type":"4"}},{"id":1713986,"issuer":{"id":7572,"kind":"organization","name":"Cellectar Biosciences, Inc."},"owners":[{"id":89770,"kind":"person","name":"Shustov Andrei","position":1,"cik":"0001969686","reported_name":"Shustov Andrei","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Senior Vice President, Medical"}}],"security":"Common Stock","published_at":"2023-12-13T01:05:40.000Z","date":"2023-12-08","kind":"grant","planned":false,"acquired":true,"shares":47856,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":55037.7,"source":{"system":"sec-edgar","filing":"0001104659-23-125485","document":"tm2332764-5_4seq1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1279704/000110465923125485/tm2332764-5_4seq1.xml","form_type":"4"}},{"id":1713988,"issuer":{"id":7572,"kind":"organization","name":"Cellectar Biosciences, Inc."},"owners":[{"id":31407,"kind":"person","name":"Longcor Jarrod","position":1,"cik":"0001545565","reported_name":"Longcor Jarrod","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Operating Officer"}}],"security":"Stock option (right to buy)","published_at":"2023-12-13T01:04:10.000Z","date":"2023-06-23","kind":"grant","planned":false,"acquired":true,"shares":144000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"date","element":"transactionDate","label":"F1","text":"This option was contingently granted on January 16, 2023, subject to approval by Cellectar's stockholders of Cellectar's amended 2021 Stock Incentive Plan at Cellectar's 2023 Annual Meeting of Stockholders. Such stockholder approval was obtained on June 23, 2023. Because January 16, 2023 was a federal holiday, the option was priced on the following trading day."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"This option shall vest over a period of three years from January 17, 2023, with 1/3 vesting on the first anniversary of January 17, 2023 and the remainder vesting in 24 equal monthly installments over a 24-month period beginning on the first anniversary of January 17, 2023."}],"balance_after":144000,"derivative":{"exercise_price":1.68,"expiration_date":"2033-01-17","underlying":"Common Stock","underlying_shares":144000},"source":{"system":"sec-edgar","filing":"0001104659-23-125484","document":"tm2332764-4_4seq1.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1279704/000110465923125484/tm2332764-4_4seq1.xml","form_type":"4"}},{"id":1713987,"issuer":{"id":7572,"kind":"organization","name":"Cellectar Biosciences, Inc."},"owners":[{"id":31407,"kind":"person","name":"Longcor Jarrod","position":1,"cik":"0001545565","reported_name":"Longcor Jarrod","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Operating Officer"}}],"security":"Common Stock","published_at":"2023-12-13T01:04:10.000Z","date":"2023-12-08","kind":"grant","planned":false,"acquired":true,"shares":42927,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":53141,"source":{"system":"sec-edgar","filing":"0001104659-23-125484","document":"tm2332764-4_4seq1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1279704/000110465923125484/tm2332764-4_4seq1.xml","form_type":"4"}},{"id":1713985,"issuer":{"id":7572,"kind":"organization","name":"Cellectar Biosciences, Inc."},"owners":[{"id":31410,"kind":"person","name":"CARUSO JAMES V","position":1,"cik":"0001202770","reported_name":"CARUSO JAMES V","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and CEO"}}],"security":"Stock option (right to buy)","published_at":"2023-12-13T01:04:06.000Z","date":"2023-06-23","kind":"grant","planned":false,"acquired":true,"shares":261000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"date","element":"transactionDate","label":"F1","text":"This option was contingently granted on January 16, 2023, subject to approval by Cellectar's stockholders of Cellectar's amended 2021 Stock Incentive Plan at Cellectar's 2023 Annual Meeting of Stockholders. Such stockholder approval was obtained on June 23, 2023. Because January 16, 2023 was a federal holiday, the option was priced on the following trading day."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"This option shall vest over a period of three years from January 17, 2023, with 1/3 vesting on the first anniversary of January 17, 2023 and the remainder vesting in 24 equal monthly installments over a 24-month period beginning on the first anniversary of January 17, 2023."}],"balance_after":261000,"derivative":{"exercise_price":1.68,"expiration_date":"2033-01-17","underlying":"Common Stock","underlying_shares":261000},"source":{"system":"sec-edgar","filing":"0001104659-23-125483","document":"tm2332764-1_4seq1.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1279704/000110465923125483/tm2332764-1_4seq1.xml","form_type":"4"}},{"id":1713984,"issuer":{"id":7572,"kind":"organization","name":"Cellectar Biosciences, Inc."},"owners":[{"id":31410,"kind":"person","name":"CARUSO JAMES V","position":1,"cik":"0001202770","reported_name":"CARUSO JAMES V","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and CEO"}}],"security":"Common Stock","published_at":"2023-12-13T01:04:06.000Z","date":"2023-12-08","kind":"grant","planned":false,"acquired":true,"shares":40596,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":49236,"source":{"system":"sec-edgar","filing":"0001104659-23-125483","document":"tm2332764-1_4seq1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1279704/000110465923125483/tm2332764-1_4seq1.xml","form_type":"4"}},{"id":1842610,"issuer":{"id":7572,"kind":"organization","name":"Cellectar Biosciences, Inc."},"owners":[{"id":31408,"kind":"person","name":"Swirsky Douglas J","position":1,"cik":"0001375884","reported_name":"Swirsky Douglas J","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock option (right to buy)","published_at":"2023-06-28T22:27:07.000Z","date":"2023-06-28","kind":"grant","planned":false,"acquired":true,"shares":37500,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"This stock option shall vest in full on June 28, 2024, subject to the reporting person's continued service through the applicable vesting date."}],"balance_after":71925,"derivative":{"exercise_price":1.85,"expiration_date":"2033-06-28","underlying":"Common Stock","underlying_shares":37500},"source":{"system":"sec-edgar","filing":"0001104659-23-075942","document":"tm2320030-5_4seq1.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1279704/000110465923075942/tm2320030-5_4seq1.xml","form_type":"4"}},{"id":1842845,"issuer":{"id":7572,"kind":"organization","name":"Cellectar Biosciences, Inc."},"owners":[{"id":31493,"kind":"person","name":"NEIS JOHN","position":1,"cik":"0001167426","reported_name":"NEIS JOHN","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock option (right to buy)","published_at":"2023-06-28T22:26:14.000Z","date":"2023-06-28","kind":"grant","planned":false,"acquired":true,"shares":25000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"This stock option shall vest in full on June 28, 2024, subject to the reporting person's continued service through the applicable vesting date."}],"balance_after":47887,"derivative":{"exercise_price":1.85,"expiration_date":"2033-06-28","underlying":"Common Stock","underlying_shares":25000},"source":{"system":"sec-edgar","filing":"0001104659-23-075940","document":"tm2320030-4_4seq1.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1167426/000110465923075940/tm2320030-4_4seq1.xml","form_type":"4"}},{"id":1842640,"issuer":{"id":7572,"kind":"organization","name":"Cellectar Biosciences, Inc."},"owners":[{"id":30981,"kind":"person","name":"Loren Stefan","position":1,"cik":"0001441500","reported_name":"Loren Stefan","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock option (right to buy)","published_at":"2023-06-28T22:25:32.000Z","date":"2023-06-28","kind":"grant","planned":false,"acquired":true,"shares":25000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"This stock option shall vest in full on June 28, 2024, subject to the reporting person's continued service through the applicable vesting date."}],"balance_after":47885,"derivative":{"exercise_price":1.85,"expiration_date":"2033-06-28","underlying":"Common Stock","underlying_shares":25000},"source":{"system":"sec-edgar","filing":"0001104659-23-075939","document":"tm2320030-3_4seq1.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1441500/000110465923075939/tm2320030-3_4seq1.xml","form_type":"4"}},{"id":1842895,"issuer":{"id":7572,"kind":"organization","name":"Cellectar Biosciences, Inc."},"owners":[{"id":31497,"kind":"person","name":"DRISCOLL FREDERICK W","position":1,"cik":"0001129890","reported_name":"DRISCOLL FREDERICK W","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock option (right to buy)","published_at":"2023-06-28T22:24:30.000Z","date":"2023-06-28","kind":"grant","planned":false,"acquired":true,"shares":25000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"This stock option shall vest in full on June 28, 2024, subject to the reporting person's continued service through the applicable vesting date."}],"balance_after":47650,"derivative":{"exercise_price":1.85,"expiration_date":"2033-06-28","underlying":"Common Stock","underlying_shares":25000},"source":{"system":"sec-edgar","filing":"0001104659-23-075938","document":"tm2320030-2_4seq1.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1129890/000110465923075938/tm2320030-2_4seq1.xml","form_type":"4"}},{"id":1842813,"issuer":{"id":7572,"kind":"organization","name":"Cellectar Biosciences, Inc."},"owners":[{"id":31455,"kind":"person","name":"Chanan-Khan Asher","position":1,"cik":"0001869837","reported_name":"Chanan-Khan Asher","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock option (right to buy)","published_at":"2023-06-28T22:24:00.000Z","date":"2023-06-28","kind":"grant","planned":false,"acquired":true,"shares":25000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"This stock option shall vest in full on June 28, 2024, subject to the reporting person's continued service through the applicable vesting date."}],"balance_after":40600,"derivative":{"exercise_price":1.85,"expiration_date":"2033-06-28","underlying":"Common Stock","underlying_shares":25000},"source":{"system":"sec-edgar","filing":"0001104659-23-075937","document":"tm2320030-1_4seq1.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1869837/000110465923075937/tm2320030-1_4seq1.xml","form_type":"4"}},{"id":1949862,"issuer":{"id":7572,"kind":"organization","name":"Cellectar Biosciences, Inc."},"owners":[{"id":89770,"kind":"person","name":"Shustov Andrei","position":1,"cik":"0001969686","reported_name":"Shustov Andrei","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Senior Vice President, Medical"}}],"security":"Stock option (right to buy)","published_at":"2023-03-16T22:02:08.000Z","date":"2023-02-15","kind":"grant","acquired":true,"shares":100000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"This option shall vest in three approximately equal annual installments beginning on the first anniversary of the date of grant, subject to the Reporting Person's continuous employment by the Issuer on each vesting date."}],"balance_after":100000,"derivative":{"exercise_price":1.67,"expiration_date":"2033-02-15","underlying":"Common Stock","underlying_shares":100000},"source":{"system":"sec-edgar","filing":"0001104659-23-033409","document":"tm239814d2_4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1279704/000110465923033409/tm239814d2_4.xml","form_type":"4"}},{"id":2052236,"issuer":{"id":7572,"kind":"organization","name":"Cellectar Biosciences, Inc."},"owners":[{"id":31407,"kind":"person","name":"Longcor Jarrod","position":1,"cik":"0001545565","reported_name":"Longcor Jarrod","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Operating Officer"}}],"security":"Stock option (right to buy)","published_at":"2023-01-18T23:34:57.000Z","date":"2023-01-17","kind":"grant","acquired":true,"shares":144000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"This option shall vest over a period of three years from the grant date, with 1/3 vesting on the first anniversary of the grant date and the remainder vesting in 24 equal monthly installments over a 24 month period beginning on the first anniversary of the grant date."}],"balance_after":144000,"derivative":{"exercise_price":1.68,"expiration_date":"2033-01-17","underlying":"Common Stock","underlying_shares":144000},"source":{"system":"sec-edgar","filing":"0001104659-23-004701","document":"tm233841-3_4seq1.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1279704/000110465923004701/tm233841-3_4seq1.xml","form_type":"4"}},{"id":2052235,"issuer":{"id":7572,"kind":"organization","name":"Cellectar Biosciences, Inc."},"owners":[{"id":31410,"kind":"person","name":"CARUSO JAMES V","position":1,"cik":"0001202770","reported_name":"CARUSO JAMES V","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and CEO"}}],"security":"Stock option (right to buy)","published_at":"2023-01-18T23:34:03.000Z","date":"2023-01-17","kind":"grant","acquired":true,"shares":261000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"This option shall vest over a period of three years from the grant date, with 1/3 vesting on the first anniversary of the grant date and the remainder vesting in 24 equal monthly installments over a 24 month period beginning on the first anniversary of the grant date."}],"balance_after":261000,"derivative":{"exercise_price":1.68,"expiration_date":"2033-01-17","underlying":"Common Stock","underlying_shares":261000},"source":{"system":"sec-edgar","filing":"0001104659-23-004700","document":"tm233841-2_4seq1.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1279704/000110465923004700/tm233841-2_4seq1.xml","form_type":"4"}},{"id":2052234,"issuer":{"id":7572,"kind":"organization","name":"Cellectar Biosciences, Inc."},"owners":[{"id":31411,"kind":"person","name":"Kolean Chad J","position":1,"cik":"0001616753","reported_name":"Kolean Chad J","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Stock option (right to buy)","published_at":"2023-01-18T23:33:02.000Z","date":"2023-01-17","kind":"grant","acquired":true,"shares":104000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"This option shall vest over a period of three years from the grant date, with 1/3 vesting on the first anniversary of the grant date and the remainder vesting in 24 equal monthly installments over a 24 month period beginning on the first anniversary of the grant date."}],"balance_after":104000,"derivative":{"exercise_price":1.68,"expiration_date":"2033-01-17","underlying":"Common Stock","underlying_shares":104000},"source":{"system":"sec-edgar","filing":"0001104659-23-004699","document":"tm233841-1_4seq1.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1279704/000110465923004699/tm233841-1_4seq1.xml","form_type":"4"}},{"id":2084950,"issuer":{"id":7572,"kind":"organization","name":"Cellectar Biosciences, Inc."},"owners":[{"id":89769,"kind":"person","name":"Lea Darrell Shane","position":1,"cik":"0001958526","reported_name":"Lea Darrell Shane","relationship":{"officer":true,"officer_title":"Chief Commercial Officer"}}],"security":"Stock option (right to buy)","published_at":"2022-12-15T22:00:43.000Z","date":"2022-11-21","kind":"grant","acquired":true,"shares":100000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"This option shall vest in three equal annual installments beginning on the first anniversary of the date of grant, subject to the Reporting Person's continuous employment by the Issuer on each vesting date."}],"balance_after":100000,"derivative":{"exercise_price":1.9,"expiration_date":"2032-11-21","underlying":"Common Stock","underlying_shares":100000},"source":{"system":"sec-edgar","filing":"0001140361-22-045712","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1279704/000114036122045712/form4.xml","form_type":"4"}},{"id":2198957,"issuer":{"id":7572,"kind":"organization","name":"Cellectar Biosciences, Inc."},"owners":[{"id":31408,"kind":"person","name":"Swirsky Douglas J","position":1,"cik":"0001375884","reported_name":"Swirsky Douglas J","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock option (right to buy)","published_at":"2022-08-01T22:01:54.000Z","date":"2022-06-24","kind":"grant","acquired":true,"shares":11700,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Exercise price and quantity have been adjusted for the one-for-ten (1:10) reverse stock split effected by the Issuer on July 21, 2022."},{"field":"shares","element":"transactionShares","label":"F1","text":"Exercise price and quantity have been adjusted for the one-for-ten (1:10) reverse stock split effected by the Issuer on July 21, 2022."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"This stock option shall vest in full on June 24, 2023, subject to the reporting person's continued service through the applicable vesting date."},{"field":"derivative.underlying_shares","element":"underlyingSecurityShares","label":"F1","text":"Exercise price and quantity have been adjusted for the one-for-ten (1:10) reverse stock split effected by the Issuer on July 21, 2022."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F1","text":"Exercise price and quantity have been adjusted for the one-for-ten (1:10) reverse stock split effected by the Issuer on July 21, 2022."}],"balance_after":11700,"derivative":{"exercise_price":4.1,"expiration_date":"2032-06-24","underlying":"Common Stock","underlying_shares":11700},"source":{"system":"sec-edgar","filing":"0001104659-22-084839","document":"tm2222253-5_4seq1.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1279704/000110465922084839/tm2222253-5_4seq1.xml","form_type":"4"}},{"id":2199228,"issuer":{"id":7572,"kind":"organization","name":"Cellectar Biosciences, Inc."},"owners":[{"id":31493,"kind":"person","name":"NEIS JOHN","position":1,"cik":"0001167426","reported_name":"NEIS JOHN","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock option (right to buy)","published_at":"2022-08-01T22:01:38.000Z","date":"2022-06-24","kind":"grant","acquired":true,"shares":7800,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Exercise price and quantity have been adjusted for the one-for-ten (1:10) reverse stock split effected by the Issuer on July 21, 2022."},{"field":"shares","element":"transactionShares","label":"F1","text":"Exercise price and quantity have been adjusted for the one-for-ten (1:10) reverse stock split effected by the Issuer on July 21, 2022."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"This stock option shall vest in full on June 24, 2023, subject to the reporting person's continued service through the applicable vesting date."},{"field":"derivative.underlying_shares","element":"underlyingSecurityShares","label":"F1","text":"Exercise price and quantity have been adjusted for the one-for-ten (1:10) reverse stock split effected by the Issuer on July 21, 2022."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F1","text":"Exercise price and quantity have been adjusted for the one-for-ten (1:10) reverse stock split effected by the Issuer on July 21, 2022."}],"balance_after":7800,"derivative":{"exercise_price":4.1,"expiration_date":"2032-06-24","underlying":"Common Stock","underlying_shares":7800},"source":{"system":"sec-edgar","filing":"0001104659-22-084838","document":"tm2222253-4_4seq1.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1167426/000110465922084838/tm2222253-4_4seq1.xml","form_type":"4"}},{"id":2199004,"issuer":{"id":7572,"kind":"organization","name":"Cellectar Biosciences, Inc."},"owners":[{"id":30981,"kind":"person","name":"Loren Stefan","position":1,"cik":"0001441500","reported_name":"Loren Stefan","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock option (right to buy)","published_at":"2022-08-01T22:01:20.000Z","date":"2022-06-24","kind":"grant","acquired":true,"shares":7800,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Exercise price and quantity have been adjusted for the one-for-ten (1:10) reverse stock split effected by the Issuer on July 21, 2022."},{"field":"shares","element":"transactionShares","label":"F1","text":"Exercise price and quantity have been adjusted for the one-for-ten (1:10) reverse stock split effected by the Issuer on July 21, 2022."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"This stock option shall vest in full on June 24, 2023, subject to the reporting person's continued service through the applicable vesting date."},{"field":"derivative.underlying_shares","element":"underlyingSecurityShares","label":"F1","text":"Exercise price and quantity have been adjusted for the one-for-ten (1:10) reverse stock split effected by the Issuer on July 21, 2022."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F1","text":"Exercise price and quantity have been adjusted for the one-for-ten (1:10) reverse stock split effected by the Issuer on July 21, 2022."}],"balance_after":7800,"derivative":{"exercise_price":4.1,"expiration_date":"2032-06-24","underlying":"Common Stock","underlying_shares":7800},"source":{"system":"sec-edgar","filing":"0001104659-22-084837","document":"tm2222253-3_4seq1.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1441500/000110465922084837/tm2222253-3_4seq1.xml","form_type":"4"}},{"id":2199239,"issuer":{"id":7572,"kind":"organization","name":"Cellectar Biosciences, Inc."},"owners":[{"id":31497,"kind":"person","name":"DRISCOLL FREDERICK W","position":1,"cik":"0001129890","reported_name":"DRISCOLL FREDERICK W","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock option (right to buy)","published_at":"2022-08-01T22:00:54.000Z","date":"2022-06-24","kind":"grant","acquired":true,"shares":7800,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Exercise price and quantity have been adjusted for the one-for-ten (1:10) reverse stock split effected by the Issuer on July 21, 2022."},{"field":"shares","element":"transactionShares","label":"F1","text":"Exercise price and quantity have been adjusted for the one-for-ten (1:10) reverse stock split effected by the Issuer on July 21, 2022."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"This stock option shall vest in full on June 24, 2023, subject to the reporting person's continued service through the applicable vesting date."},{"field":"derivative.underlying_shares","element":"underlyingSecurityShares","label":"F1","text":"Exercise price and quantity have been adjusted for the one-for-ten (1:10) reverse stock split effected by the Issuer on July 21, 2022."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F1","text":"Exercise price and quantity have been adjusted for the one-for-ten (1:10) reverse stock split effected by the Issuer on July 21, 2022."}],"balance_after":7800,"derivative":{"exercise_price":4.1,"expiration_date":"2032-06-24","underlying":"Common Stock","underlying_shares":7800},"source":{"system":"sec-edgar","filing":"0001104659-22-084835","document":"tm2222253-2_4seq1.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1129890/000110465922084835/tm2222253-2_4seq1.xml","form_type":"4"}},{"id":2199181,"issuer":{"id":7572,"kind":"organization","name":"Cellectar Biosciences, Inc."},"owners":[{"id":31455,"kind":"person","name":"Chanan-Khan Asher","position":1,"cik":"0001869837","reported_name":"Chanan-Khan Asher","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock option (right to buy)","published_at":"2022-08-01T22:00:52.000Z","date":"2022-06-24","kind":"grant","acquired":true,"shares":7800,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Exercise price and quantity have been adjusted for the one-for-ten (1:10) reverse stock split effected by the Issuer on July 21, 2022."},{"field":"shares","element":"transactionShares","label":"F1","text":"Exercise price and quantity have been adjusted for the one-for-ten (1:10) reverse stock split effected by the Issuer on July 21, 2022."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"This stock option shall vest in full on June 24, 2023, subject to the reporting person's continued service through the applicable vesting date."},{"field":"derivative.underlying_shares","element":"underlyingSecurityShares","label":"F1","text":"Exercise price and quantity have been adjusted for the one-for-ten (1:10) reverse stock split effected by the Issuer on July 21, 2022."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F1","text":"Exercise price and quantity have been adjusted for the one-for-ten (1:10) reverse stock split effected by the Issuer on July 21, 2022."}],"balance_after":7800,"derivative":{"exercise_price":4.1,"expiration_date":"2032-06-24","underlying":"Common Stock","underlying_shares":7800},"source":{"system":"sec-edgar","filing":"0001104659-22-084832","document":"tm2222253-1_4seq1.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1869837/000110465922084832/tm2222253-1_4seq1.xml","form_type":"4"}},{"id":2374410,"issuer":{"id":7572,"kind":"organization","name":"Cellectar Biosciences, Inc."},"owners":[{"id":31411,"kind":"person","name":"Kolean Chad J","position":1,"cik":"0001616753","reported_name":"Kolean Chad J","relationship":{"officer":true,"officer_title":"Chief Financial Officer"}}],"security":"Stock option (right to buy)","published_at":"2022-02-24T22:00:59.000Z","date":"2022-02-22","kind":"grant","acquired":true,"shares":150000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"This option shall vest in three equal annual installments beginning on the first anniversary of the date of grant."}],"balance_after":150000,"derivative":{"exercise_price":0.49,"expiration_date":"2032-02-22","underlying":"Common Stock","underlying_shares":150000},"source":{"system":"sec-edgar","filing":"0001140361-22-006594","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1279704/000114036122006594/form4.xml","form_type":"4"}},{"id":2423962,"issuer":{"id":7572,"kind":"organization","name":"Cellectar Biosciences, Inc."},"owners":[{"id":31407,"kind":"person","name":"Longcor Jarrod","position":1,"cik":"0001545565","reported_name":"Longcor Jarrod","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Business Officer"}}],"security":"Stock option (right to buy)","published_at":"2022-01-27T21:06:19.000Z","date":"2022-01-25","kind":"grant","acquired":true,"shares":475000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"This option shall vest over a period of three years from the grant date, with 1/3 vesting on the first anniversary of the grant date and the remainder vesting in 24 equal monthly installments over a 24 month period beginning on the first anniversary of the grant date."}],"balance_after":475000,"derivative":{"exercise_price":0.55,"expiration_date":"2032-01-25","underlying":"Common Stock","underlying_shares":475000},"source":{"system":"sec-edgar","filing":"0001104659-22-008280","document":"tm224689-3_4seq1.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1279704/000110465922008280/tm224689-3_4seq1.xml","form_type":"4"}},{"id":2423916,"issuer":{"id":7572,"kind":"organization","name":"Cellectar Biosciences, Inc."},"owners":[{"id":24569,"kind":"person","name":"Elefant Dov","position":1,"cik":"0001326487","reported_name":"Elefant Dov","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Stock option (right to buy)","published_at":"2022-01-27T21:06:06.000Z","date":"2022-01-25","kind":"grant","acquired":true,"shares":422000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"This option shall vest over a period of three years from the grant date, with 1/3 vesting on the first anniversary of the grant date and the remainder vesting in 24 equal monthly installments over a 24 month period beginning on the first anniversary of the grant date."}],"balance_after":422000,"derivative":{"exercise_price":0.55,"expiration_date":"2032-01-25","underlying":"Common Stock","underlying_shares":422000},"source":{"system":"sec-edgar","filing":"0001104659-22-008278","document":"tm224689-2_4seq1.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1326487/000110465922008278/tm224689-2_4seq1.xml","form_type":"4"}},{"id":2423903,"issuer":{"id":7572,"kind":"organization","name":"Cellectar Biosciences, Inc."},"owners":[{"id":31410,"kind":"person","name":"CARUSO JAMES V","position":1,"cik":"0001202770","reported_name":"CARUSO JAMES V","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and CEO"}}],"security":"Stock option (right to buy)","published_at":"2022-01-27T21:05:46.000Z","date":"2022-01-25","kind":"grant","acquired":true,"shares":1419000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"This option shall vest over a period of three years from the grant date, with 1/3 vesting on the first anniversary of the grant date and the remainder vesting in 24 equal monthly installments over a 24 month period beginning on the first anniversary of the grant date."}],"balance_after":1419000,"derivative":{"exercise_price":0.55,"expiration_date":"2032-01-25","underlying":"Common Stock","underlying_shares":1419000},"source":{"system":"sec-edgar","filing":"0001104659-22-008277","document":"tm224689-1_4seq1.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1279704/000110465922008277/tm224689-1_4seq1.xml","form_type":"4"}},{"id":2570593,"issuer":{"id":7572,"kind":"organization","name":"Cellectar Biosciences, Inc."},"owners":[{"id":31408,"kind":"person","name":"Swirsky Douglas J","position":1,"cik":"0001375884","reported_name":"Swirsky Douglas J","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2021-09-14T20:00:56.000Z","date":"2021-09-14","kind":"purchase","acquired":true,"shares":25000,"price":1.04,"value":26000.0,"ownership":{"direct":true},"balance_after":25000,"source":{"system":"sec-edgar","filing":"0001104659-21-115477","document":"tm2127646-1_4seq1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1279704/000110465921115477/tm2127646-1_4seq1.xml","form_type":"4"}},{"id":2577560,"issuer":{"id":7572,"kind":"organization","name":"Cellectar Biosciences, Inc."},"owners":[{"id":31497,"kind":"person","name":"DRISCOLL FREDERICK W","position":1,"cik":"0001129890","reported_name":"DRISCOLL FREDERICK W","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2021-09-07T20:01:41.000Z","date":"2021-09-03","kind":"purchase","acquired":true,"shares":19417,"price":1.0426,"value":20244.1642,"ownership":{"direct":true},"balance_after":19417,"source":{"system":"sec-edgar","filing":"0001104659-21-113416","document":"tm2127071-1_4seq1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1129890/000110465921113416/tm2127071-1_4seq1.xml","form_type":"4"}},{"id":2644117,"issuer":{"id":7572,"kind":"organization","name":"Cellectar Biosciences, Inc."},"owners":[{"id":31408,"kind":"person","name":"Swirsky Douglas J","position":1,"cik":"0001375884","reported_name":"Swirsky Douglas J","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock option (right to buy)","published_at":"2021-07-02T20:04:10.000Z","date":"2021-06-30","kind":"grant","acquired":true,"shares":117000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"This option shall vest on the first anniversary of the date of grant."}],"balance_after":117000,"derivative":{"exercise_price":1.19,"expiration_date":"2031-06-30","underlying":"Common Stock","underlying_shares":117000},"source":{"system":"sec-edgar","filing":"0001104659-21-088842","document":"tm2120855-6_4seq1.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1279704/000110465921088842/tm2120855-6_4seq1.xml","form_type":"4"}},{"id":2645381,"issuer":{"id":7572,"kind":"organization","name":"Cellectar Biosciences, Inc."},"owners":[{"id":31493,"kind":"person","name":"NEIS JOHN","position":1,"cik":"0001167426","reported_name":"NEIS JOHN","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock option (right to buy)","published_at":"2021-07-02T20:03:32.000Z","date":"2021-06-30","kind":"grant","acquired":true,"shares":78000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"This option shall vest on the first anniversary of the date of grant."}],"balance_after":78000,"derivative":{"exercise_price":1.19,"expiration_date":"2031-06-30","underlying":"Common Stock","underlying_shares":78000},"source":{"system":"sec-edgar","filing":"0001104659-21-088841","document":"tm2120855-5_4seq1.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1167426/000110465921088841/tm2120855-5_4seq1.xml","form_type":"4"}},{"id":2644444,"issuer":{"id":7572,"kind":"organization","name":"Cellectar Biosciences, Inc."},"owners":[{"id":30981,"kind":"person","name":"Loren Stefan","position":1,"cik":"0001441500","reported_name":"Loren Stefan","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock option (right to buy)","published_at":"2021-07-02T20:03:32.000Z","date":"2021-06-30","kind":"grant","acquired":true,"shares":78000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"This option shall vest on the first anniversary of the date of grant."}],"balance_after":78000,"derivative":{"exercise_price":1.19,"expiration_date":"2031-06-30","underlying":"Common Stock","underlying_shares":78000},"source":{"system":"sec-edgar","filing":"0001104659-21-088839","document":"tm2120855-4_4seq1.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1441500/000110465921088839/tm2120855-4_4seq1.xml","form_type":"4"}},{"id":2645447,"issuer":{"id":7572,"kind":"organization","name":"Cellectar Biosciences, Inc."},"owners":[{"id":31497,"kind":"person","name":"DRISCOLL FREDERICK W","position":1,"cik":"0001129890","reported_name":"DRISCOLL FREDERICK W","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock option (right to buy)","published_at":"2021-07-02T20:03:06.000Z","date":"2021-06-30","kind":"grant","acquired":true,"shares":78000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"This option shall vest on the first anniversary of the date of grant."}],"balance_after":78000,"derivative":{"exercise_price":1.19,"expiration_date":"2031-06-30","underlying":"Common Stock","underlying_shares":78000},"source":{"system":"sec-edgar","filing":"0001104659-21-088836","document":"tm2120855-3_4seq1.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1129890/000110465921088836/tm2120855-3_4seq1.xml","form_type":"4"}},{"id":2645337,"issuer":{"id":7572,"kind":"organization","name":"Cellectar Biosciences, Inc."},"owners":[{"id":31455,"kind":"person","name":"Chanan-Khan Asher","position":1,"cik":"0001869837","reported_name":"Chanan-Khan Asher","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock option (right to buy)","published_at":"2021-07-02T20:02:34.000Z","date":"2021-06-30","kind":"grant","acquired":true,"shares":78000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Stock option vest in equal annual increments on June 30, 2022, June 30, 2023, and June 30, 2024."}],"balance_after":78000,"derivative":{"exercise_price":1.19,"expiration_date":"2031-06-30","underlying":"Common Stock","underlying_shares":78000},"source":{"system":"sec-edgar","filing":"0001104659-21-088833","document":"tm2120855-2_4seq1.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1869837/000110465921088833/tm2120855-2_4seq1.xml","form_type":"4"}},{"id":2777797,"issuer":{"id":7572,"kind":"organization","name":"Cellectar Biosciences, Inc."},"owners":[{"id":31493,"kind":"person","name":"NEIS JOHN","position":1,"cik":"0001167426","reported_name":"NEIS JOHN","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Series A Warrants","published_at":"2021-03-19T20:06:14.000Z","date":"2021-03-18","kind":"sale","acquired":false,"shares":23232,"price":0.2522,"value":5859.1104,"ownership":{"direct":true},"footnotes":[{"field":"derivative.underlying_shares","element":"underlyingSecurityShares","label":"F2","text":"The price reported is a weighted average price. These warrants were sold in multiple transactions at prices ranging from $0.24 and $0.27, inclusive. The reporting person undertakes to provide the staff of the Securities and Exchange Commission, upon request, full information regarding the number of warrants sold at each separate price within the ranges set forth in footnote (2) to this Form 4."}],"balance_after":0,"derivative":{"exercise_price":30.4,"exercise_date":"2016-04-20","expiration_date":"2021-04-20","underlying":"Common Stock","underlying_shares":2323},"source":{"system":"sec-edgar","filing":"0001104659-21-039056","document":"tm2110277d1_4seq1.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1167426/000110465921039056/tm2110277d1_4seq1.xml","form_type":"4"}},{"id":2777796,"issuer":{"id":7572,"kind":"organization","name":"Cellectar Biosciences, Inc."},"owners":[{"id":31493,"kind":"person","name":"NEIS JOHN","position":1,"cik":"0001167426","reported_name":"NEIS JOHN","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Series A Warrants","published_at":"2021-03-19T20:06:14.000Z","date":"2021-03-17","kind":"sale","acquired":false,"shares":58640,"price":0.2775,"value":16272.6,"ownership":{"direct":true},"footnotes":[{"field":"derivative.underlying_shares","element":"underlyingSecurityShares","label":"F1","text":"The price reported is a weighted average price. These warrants were sold in multiple transactions at prices ranging from $0.27 and $0.2845, inclusive. The reporting person undertakes to provide the staff of the Securities and Exchange Commission, upon request, full information regarding the number of warrants sold at each separate price within the ranges set forth in footnote (1) to this Form 4."}],"balance_after":23232,"derivative":{"exercise_price":30.4,"exercise_date":"2016-04-20","expiration_date":"2021-04-20","underlying":"Common Stock","underlying_shares":5864},"source":{"system":"sec-edgar","filing":"0001104659-21-039056","document":"tm2110277d1_4seq1.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1167426/000110465921039056/tm2110277d1_4seq1.xml","form_type":"4"}},{"id":2786703,"issuer":{"id":7572,"kind":"organization","name":"Cellectar Biosciences, Inc."},"owners":[{"id":31493,"kind":"person","name":"NEIS JOHN","position":1,"cik":"0001167426","reported_name":"NEIS JOHN","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Series A Warrants","published_at":"2021-03-17T00:54:06.000Z","date":"2021-03-16","kind":"sale","acquired":false,"shares":100515,"price":0.3091,"value":31069.1865,"ownership":{"direct":true},"footnotes":[{"field":"derivative.underlying_shares","element":"underlyingSecurityShares","label":"F3","text":"The price reported is a weighted average price. These warrants were sold in multiple transactions at prices ranging from $0.28 and $0.34, inclusive. The reporting person undertakes to provide the staff of the Securities and Exchange Commission, upon request, full information regarding the number of warrants sold at each separate price within the ranges set forth in footnote (3) to this Form 4."}],"balance_after":81872,"derivative":{"exercise_price":30.4,"exercise_date":"2016-04-20","expiration_date":"2021-04-20","underlying":"Common Stock","underlying_shares":10051},"source":{"system":"sec-edgar","filing":"0001104659-21-037323","document":"tm2110008d1_4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1167426/000110465921037323/tm2110008d1_4.xml","form_type":"4"}},{"id":2786702,"issuer":{"id":7572,"kind":"organization","name":"Cellectar Biosciences, Inc."},"owners":[{"id":31493,"kind":"person","name":"NEIS JOHN","position":1,"cik":"0001167426","reported_name":"NEIS JOHN","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Series A Warrants","published_at":"2021-03-17T00:54:06.000Z","date":"2021-03-15","kind":"sale","acquired":false,"shares":11200,"price":0.2652,"value":2970.24,"ownership":{"direct":true},"footnotes":[{"field":"derivative.underlying_shares","element":"underlyingSecurityShares","label":"F2","text":"The price reported is a weighted average price. These warrants were sold in multiple transactions at prices ranging from $0.265 and $0.2666, inclusive. The reporting person undertakes to provide the staff of the Securities and Exchange Commission, upon request, full information regarding the number of warrants sold at each separate price within the ranges set forth in footnote (2) to this Form 4."}],"balance_after":182387,"derivative":{"exercise_price":30.4,"exercise_date":"2016-04-20","expiration_date":"2021-04-20","underlying":"Common Stock","underlying_shares":1120},"source":{"system":"sec-edgar","filing":"0001104659-21-037323","document":"tm2110008d1_4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1167426/000110465921037323/tm2110008d1_4.xml","form_type":"4"}},{"id":2786701,"issuer":{"id":7572,"kind":"organization","name":"Cellectar Biosciences, Inc."},"owners":[{"id":31493,"kind":"person","name":"NEIS JOHN","position":1,"cik":"0001167426","reported_name":"NEIS JOHN","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Series A Warrants","published_at":"2021-03-17T00:54:06.000Z","date":"2021-03-12","kind":"sale","acquired":false,"shares":41155,"price":0.2668,"value":10980.154,"ownership":{"direct":true},"footnotes":[{"field":"derivative.underlying_shares","element":"underlyingSecurityShares","label":"F1","text":"The price reported is a weighted average price. These warrants were sold in multiple transactions at prices ranging from $0.2648 and $0.27, inclusive. The reporting person undertakes to provide the staff of the Securities and Exchange Commission, upon request, full information regarding the number of warrants sold at each separate price within the ranges set forth in footnote (1) to this Form 4."}],"balance_after":193587,"derivative":{"exercise_price":30.4,"exercise_date":"2016-04-20","expiration_date":"2021-04-20","underlying":"Common Stock","underlying_shares":4115},"source":{"system":"sec-edgar","filing":"0001104659-21-037323","document":"tm2110008d1_4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1167426/000110465921037323/tm2110008d1_4.xml","form_type":"4"}},{"id":2805694,"issuer":{"id":7572,"kind":"organization","name":"Cellectar Biosciences, Inc."},"owners":[{"id":24569,"kind":"person","name":"Elefant Dov","position":1,"cik":"0001326487","reported_name":"Elefant Dov","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Stock option (right to buy)","published_at":"2021-03-05T22:46:50.000Z","date":"2021-03-04","kind":"grant","acquired":true,"shares":430000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"This option grant is a contingent grant subject to the following conditions: (i) approval by Cellectar's stockholders of shares available under Cellectar's equity incentive plans at Cellectar's 2021 annual meeting of stockholders or other special meeting of stockholders called for such purpose; and (ii) to the extent stockholder approval is received, the grant shall vest over a period of three years form the grant date, with 1/3 vesting on the first anniversary of the grant date and the remainder vesting in 24 equal monthly installments over a 24 month period beginning on the first anniversary of the grant date."}],"balance_after":430000,"derivative":{"exercise_price":1.74,"expiration_date":"2031-03-04","underlying":"Common Stock","underlying_shares":430000},"source":{"system":"sec-edgar","filing":"0001104659-21-032853","document":"tm218888d4_4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1326487/000110465921032853/tm218888d4_4.xml","form_type":"4"}},{"id":2805647,"issuer":{"id":7572,"kind":"organization","name":"Cellectar Biosciences, Inc."},"owners":[{"id":31407,"kind":"person","name":"Longcor Jarrod","position":1,"cik":"0001545565","reported_name":"Longcor Jarrod","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Business Officer"}}],"security":"Stock option (right to buy)","published_at":"2021-03-05T22:46:33.000Z","date":"2021-03-04","kind":"grant","acquired":true,"shares":450000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"This option grant is a contingent grant subject to the following conditions: (i) approval by Cellectar's stockholders of shares available under Cellectar's equity incentive plans at Cellectar's 2021 annual meeting of stockholders or other special meeting of stockholders called for such purpose; and (ii) to the extent stockholder approval is received, the grant shall vest over a period of three years from the grant date, with 1/3 vesting on the first anniversary of the grant date and the remainder vesting in 24 equal monthly installments over a 24 month period beginning on the first anniversary of the grant date."}],"balance_after":450000,"derivative":{"exercise_price":1.74,"expiration_date":"2021-03-04","underlying":"Common Stock","underlying_shares":450000},"source":{"system":"sec-edgar","filing":"0001104659-21-032852","document":"tm218888d2_4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1279704/000110465921032852/tm218888d2_4.xml","form_type":"4"}},{"id":2806380,"issuer":{"id":7572,"kind":"organization","name":"Cellectar Biosciences, Inc."},"owners":[{"id":31506,"kind":"person","name":"Friend John E. II","position":1,"cik":"0001704021","reported_name":"Friend John E. II","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Medical Officer"}}],"security":"Stock option (right to buy)","published_at":"2021-03-05T22:46:09.000Z","date":"2021-03-04","kind":"grant","acquired":true,"shares":330000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"This option grant is a contingent grant subject to the following conditions: (i) approval by Cellectar's stockholders of shares available under Cellectar's equity incentive plans at Cellectar's 2021 annual meeting of stockholders or other special meeting of stockholders called for such purpose; and (ii) to the extent stockholder approval is received, the grant shall vest over a period of three years from the grant date, with 1/3 vesting on the first anniversary of the grant date and the remainder vesting in 24 equal monthly installments over a 24 month period beginning on the first anniversary of the grant date."}],"balance_after":330000,"derivative":{"exercise_price":1.74,"expiration_date":"2021-03-04","underlying":"Common Stock","underlying_shares":330000},"source":{"system":"sec-edgar","filing":"0001104659-21-032851","document":"tm218888d1_4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1704021/000110465921032851/tm218888d1_4.xml","form_type":"4"}},{"id":2805644,"issuer":{"id":7572,"kind":"organization","name":"Cellectar Biosciences, Inc."},"owners":[{"id":31410,"kind":"person","name":"CARUSO JAMES V","position":1,"cik":"0001202770","reported_name":"CARUSO JAMES V","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and CEO"}}],"security":"Series A Warrants","published_at":"2021-03-05T22:45:39.000Z","date":"2021-03-04","kind":"sale","acquired":true,"shares":46948,"price":0.1857,"value":8718.2436,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F2","text":"Ten warrants are convertible into one share of Cellectar's common stock at an exercise price of $30.40 per share of common stock."},{"field":"shares","element":"transactionShares","label":"F1","text":"Mr. Caruso used the proceeds of the sale of the Series A Warrants, which expire in April 2021, to purchase shares of Cellectar's common stock."},{"field":"derivative.underlying_shares","element":"underlyingSecurityShares","label":"F2","text":"Ten warrants are convertible into one share of Cellectar's common stock at an exercise price of $30.40 per share of common stock."}],"balance_after":0,"derivative":{"exercise_price":30.4,"exercise_date":"2016-04-20","expiration_date":"2021-04-20","underlying":"Common Stock","underlying_shares":4694},"source":{"system":"sec-edgar","filing":"0001104659-21-032850","document":"tm218888d3_4seq1.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1279704/000110465921032850/tm218888d3_4seq1.xml","form_type":"4"}},{"id":2805643,"issuer":{"id":7572,"kind":"organization","name":"Cellectar Biosciences, Inc."},"owners":[{"id":31410,"kind":"person","name":"CARUSO JAMES V","position":1,"cik":"0001202770","reported_name":"CARUSO JAMES V","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and CEO"}}],"security":"Stock option (right to buy)","published_at":"2021-03-05T22:45:39.000Z","date":"2021-03-04","kind":"grant","acquired":true,"shares":1600000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"This option grant is a contingent grant subject to the following conditions: (i) approval by Cellectar's stockholders of shares available under Cellectar's equity incentive plans at Cellectar's 2021 annual meeting of stockholders or other special meeting of stockholders called for such purpose; and (ii) to the extent stockholder approval is received, the grant shall vest over a period of three years from the grant date, with 1/3 vesting on the first anniversary of the grant date and the remainder vesting in 24 equal monthly installments over a 24 month period beginning on the first anniversary of the grant date."}],"balance_after":1600000,"derivative":{"exercise_price":1.74,"expiration_date":"2031-03-04","underlying":"Common Stock","underlying_shares":1600000},"source":{"system":"sec-edgar","filing":"0001104659-21-032850","document":"tm218888d3_4seq1.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1279704/000110465921032850/tm218888d3_4seq1.xml","form_type":"4"}},{"id":2805642,"issuer":{"id":7572,"kind":"organization","name":"Cellectar Biosciences, Inc."},"owners":[{"id":31410,"kind":"person","name":"CARUSO JAMES V","position":1,"cik":"0001202770","reported_name":"CARUSO JAMES V","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and CEO"}}],"security":"Common Stock","published_at":"2021-03-05T22:45:39.000Z","date":"2021-03-04","kind":"purchase","acquired":true,"shares":5100,"price":1.6978,"value":8658.78,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Mr. Caruso used the proceeds of the sale of the Series A Warrants, which expire in April 2021, to purchase shares of Cellectar's common stock."}],"balance_after":86401,"source":{"system":"sec-edgar","filing":"0001104659-21-032850","document":"tm218888d3_4seq1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1279704/000110465921032850/tm218888d3_4seq1.xml","form_type":"4"}},{"id":2931114,"issuer":{"id":7572,"kind":"organization","name":"Cellectar Biosciences, Inc."},"owners":[{"id":31410,"kind":"person","name":"CARUSO JAMES V","position":1,"cik":"0001202770","reported_name":"CARUSO JAMES V","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and CEO"}}],"security":"Common Stock","published_at":"2020-12-28T21:31:23.000Z","date":"2020-12-28","kind":"purchase","acquired":true,"shares":37037,"price":1.35,"value":49999.95,"ownership":{"direct":true},"balance_after":81301,"source":{"system":"sec-edgar","filing":"0001104659-20-139787","document":"tm2039438d3_4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1279704/000110465920139787/tm2039438d3_4.xml","form_type":"4"}},{"id":2931110,"issuer":{"id":7572,"kind":"organization","name":"Cellectar Biosciences, Inc."},"owners":[{"id":31407,"kind":"person","name":"Longcor Jarrod","position":1,"cik":"0001545565","reported_name":"Longcor Jarrod","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Business Officer"}}],"security":"Common Stock","published_at":"2020-12-28T21:31:13.000Z","date":"2020-12-28","kind":"purchase","acquired":true,"shares":29630,"price":1.35,"value":40000.5,"ownership":{"direct":true},"balance_after":102148,"source":{"system":"sec-edgar","filing":"0001104659-20-139786","document":"tm2039438d2_4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1279704/000110465920139786/tm2039438d2_4.xml","form_type":"4"}},{"id":2931140,"issuer":{"id":7572,"kind":"organization","name":"Cellectar Biosciences, Inc."},"owners":[{"id":24569,"kind":"person","name":"Elefant Dov","position":1,"cik":"0001326487","reported_name":"Elefant Dov","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Common Stock","published_at":"2020-12-28T21:30:50.000Z","date":"2020-12-28","kind":"purchase","acquired":true,"shares":7407,"price":1.35,"value":9999.45,"ownership":{"direct":true},"balance_after":11755,"source":{"system":"sec-edgar","filing":"0001104659-20-139783","document":"tm2039438d1_4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1326487/000110465920139783/tm2039438d1_4.xml","form_type":"4"}},{"id":3088975,"issuer":{"id":7572,"kind":"organization","name":"Cellectar Biosciences, Inc."},"owners":[{"id":31506,"kind":"person","name":"Friend John E. II","position":1,"cik":"0001704021","reported_name":"Friend John E. II","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"VP, Chief Medical Officer"}}],"security":"Stock option (right to buy)","published_at":"2020-07-06T10:06:29.000Z","date":"2020-07-01","kind":"grant","acquired":true,"shares":100000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The option shall vest in three equal installments beginning on the first anniversary of the date of grant."}],"balance_after":100000,"derivative":{"exercise_price":1.34,"expiration_date":"2030-07-01","underlying":"Common Stock","underlying_shares":100000},"source":{"system":"sec-edgar","filing":"0001104659-20-080841","document":"tm2023996d2_4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1704021/000110465920080841/tm2023996d2_4.xml","form_type":"4"}},{"id":3099714,"issuer":{"id":7572,"kind":"organization","name":"Cellectar Biosciences, Inc."},"owners":[{"id":30981,"kind":"person","name":"Loren Stefan","position":1,"cik":"0001441500","reported_name":"Loren Stefan","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock option (right to buy)","published_at":"2020-06-25T20:24:03.000Z","date":"2020-06-24","kind":"grant","acquired":true,"shares":50000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"This option grant shall vest over a period of three years from the grant date, with one-third vesting on the first anniversary of the grant date and the remainder vesting in 24 equal monthly installments over a 24 month period beginning on the first anniversary of the grant date."}],"balance_after":50000,"derivative":{"exercise_price":1.28,"expiration_date":"2030-06-24","underlying":"Common Stock","underlying_shares":50000},"source":{"system":"sec-edgar","filing":"0001104659-20-076875","document":"tm2023456d6_4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1441500/000110465920076875/tm2023456d6_4.xml","form_type":"4"}},{"id":3100050,"issuer":{"id":7572,"kind":"organization","name":"Cellectar Biosciences, Inc."},"owners":[{"id":31493,"kind":"person","name":"NEIS JOHN","position":1,"cik":"0001167426","reported_name":"NEIS JOHN","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock option (right to buy)","published_at":"2020-06-25T20:23:26.000Z","date":"2020-06-24","kind":"grant","acquired":true,"shares":50000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"This option grant shall vest over a period of three years from the grant date, with one-third vesting on  the first anniversary of the grant date and the remainder vesting in 24 equal monthly installments over a  24 month period beginning on the first anniversary of the grant date."}],"balance_after":50000,"derivative":{"exercise_price":1.28,"expiration_date":"2030-06-24","underlying":"Common Stock","underlying_shares":50000},"source":{"system":"sec-edgar","filing":"0001104659-20-076873","document":"tm2023456d5_4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1167426/000110465920076873/tm2023456d5_4.xml","form_type":"4"}},{"id":3099660,"issuer":{"id":7572,"kind":"organization","name":"Cellectar Biosciences, Inc."},"owners":[{"id":144566,"kind":"person","name":"HILL STEPHEN A","position":1,"cik":"0001237404","reported_name":"HILL STEPHEN A","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock option (right to buy)","published_at":"2020-06-25T20:22:59.000Z","date":"2020-06-24","kind":"grant","acquired":true,"shares":50000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"This option grant shall vest over a period of three years from the grant date, with one-third vesting on  the first anniversary of the grant date and the remainder vesting in 24 equal monthly installments over a  24 month period beginning on the first anniversary of the grant date."}],"balance_after":50000,"derivative":{"exercise_price":1.28,"expiration_date":"2030-06-24","underlying":"Common Stock","underlying_shares":50000},"source":{"system":"sec-edgar","filing":"0001104659-20-076872","document":"m2023456d4_4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1279704/000110465920076872/m2023456d4_4.xml","form_type":"4"}},{"id":3099659,"issuer":{"id":7572,"kind":"organization","name":"Cellectar Biosciences, Inc."},"owners":[{"id":31408,"kind":"person","name":"Swirsky Douglas J","position":1,"cik":"0001375884","reported_name":"Swirsky Douglas J","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock option (right to buy)","published_at":"2020-06-25T20:22:18.000Z","date":"2020-06-24","kind":"grant","acquired":true,"shares":80000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"This option grant shall vest over a period of three years from the grant date, with one-third vesting on  the first anniversary of the grant date and the remainder vesting in 24 equal monthly installments over a  24 month period beginning on the first anniversary of the grant date."}],"balance_after":80000,"derivative":{"exercise_price":1.28,"expiration_date":"2030-06-24","underlying":"Common Stock","underlying_shares":80000},"source":{"system":"sec-edgar","filing":"0001104659-20-076871","document":"tm2023456d3_4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1279704/000110465920076871/tm2023456d3_4.xml","form_type":"4"}},{"id":3100075,"issuer":{"id":7572,"kind":"organization","name":"Cellectar Biosciences, Inc."},"owners":[{"id":31497,"kind":"person","name":"DRISCOLL FREDERICK W","position":1,"cik":"0001129890","reported_name":"DRISCOLL FREDERICK W","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock option (right to buy)","published_at":"2020-06-25T20:21:50.000Z","date":"2020-06-24","kind":"grant","acquired":true,"shares":50000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"This option grant shall vest over a period of three years from the grant date, with one-third vesting on  the first anniversary of the grant date and the remainder vesting in 24 equal monthly installments over a  24 month period beginning on the first anniversary of the grant date."}],"balance_after":50000,"derivative":{"exercise_price":1.28,"expiration_date":"2030-06-24","underlying":"Common Stock","underlying_shares":50000},"source":{"system":"sec-edgar","filing":"0001104659-20-076870","document":"tm2023456d2_4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1129890/000110465920076870/tm2023456d2_4.xml","form_type":"4"}},{"id":3118436,"issuer":{"id":7572,"kind":"organization","name":"Cellectar Biosciences, Inc."},"owners":[{"id":144566,"kind":"person","name":"HILL STEPHEN A","position":1,"cik":"0001237404","reported_name":"HILL STEPHEN A","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2020-06-08T20:12:14.000Z","date":"2020-06-04","kind":"purchase","acquired":true,"shares":18000,"price":1.0799,"value":19438.2,"ownership":{"direct":true},"balance_after":18000,"source":{"system":"sec-edgar","filing":"0001104659-20-070843","document":"tm2022064d4_4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1279704/000110465920070843/tm2022064d4_4.xml","form_type":"4"}},{"id":3118509,"issuer":{"id":7572,"kind":"organization","name":"Cellectar Biosciences, Inc."},"owners":[{"id":24569,"kind":"person","name":"Elefant Dov","position":1,"cik":"0001326487","reported_name":"Elefant Dov","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Series H Warrants","published_at":"2020-06-08T20:08:59.000Z","date":"2020-06-05","kind":"purchase","acquired":true,"shares":2174,"price":0.01,"value":21.74,"ownership":{"direct":true},"balance_after":2174,"derivative":{"exercise_price":1.2075,"exercise_date":"2020-06-05","expiration_date":"2025-06-05","underlying":"Common Stock","underlying_shares":2174},"source":{"system":"sec-edgar","filing":"0001104659-20-070840","document":"tm2022064d3_4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1326487/000110465920070840/tm2022064d3_4.xml","form_type":"4"}},{"id":3118508,"issuer":{"id":7572,"kind":"organization","name":"Cellectar Biosciences, Inc."},"owners":[{"id":24569,"kind":"person","name":"Elefant Dov","position":1,"cik":"0001326487","reported_name":"Elefant Dov","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Common Stock","published_at":"2020-06-08T20:08:59.000Z","date":"2020-06-05","kind":"purchase","acquired":true,"shares":4348,"price":1.145,"value":4978.46,"ownership":{"direct":true},"balance_after":4348,"source":{"system":"sec-edgar","filing":"0001104659-20-070840","document":"tm2022064d3_4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1326487/000110465920070840/tm2022064d3_4.xml","form_type":"4"}},{"id":3118435,"issuer":{"id":7572,"kind":"organization","name":"Cellectar Biosciences, Inc."},"owners":[{"id":31407,"kind":"person","name":"Longcor Jarrod","position":1,"cik":"0001545565","reported_name":"Longcor Jarrod","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Business Officer"}}],"security":"Series H Warrants","published_at":"2020-06-08T20:08:18.000Z","date":"2020-06-05","kind":"purchase","acquired":true,"shares":32609,"price":0.01,"value":326.09,"ownership":{"direct":true},"balance_after":32609,"derivative":{"exercise_price":1.2075,"exercise_date":"2020-06-05","expiration_date":"2025-06-05","underlying":"Common Stock","underlying_shares":32609},"source":{"system":"sec-edgar","filing":"0001104659-20-070839","document":"tm2022064d1_4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1279704/000110465920070839/tm2022064d1_4.xml","form_type":"4"}},{"id":3118434,"issuer":{"id":7572,"kind":"organization","name":"Cellectar Biosciences, Inc."},"owners":[{"id":31407,"kind":"person","name":"Longcor Jarrod","position":1,"cik":"0001545565","reported_name":"Longcor Jarrod","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Business Officer"}}],"security":"Common Stock","published_at":"2020-06-08T20:08:18.000Z","date":"2020-06-05","kind":"purchase","acquired":true,"shares":65218,"price":1.145,"value":74674.61,"ownership":{"direct":true},"balance_after":72518,"source":{"system":"sec-edgar","filing":"0001104659-20-070839","document":"tm2022064d1_4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1279704/000110465920070839/tm2022064d1_4.xml","form_type":"4"}}],"next_cursor":"2020-06-08T20:08:18.000000Z,3118434"}